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Abstract 
Expanding the Structural Biologist’s Tool Chest by Chemical and Biocompatible 




Advisor: Dr. Laura Juszczak 
This dissertation focuses on expanding chemical derivatization methodologies of peptides with the 
ultimate goal of studying proteins that are not amenable to traditional high-resolution structural 
techniques. The first project, conducted in the laboratory of Dr. Mandë Holford, uses improved synthetic 
and chemical derivatization methods to access and characterize peptidic natural products from venomous 
marine snails belonging to the family Terebridae. Closely related to Conus snails, the Terebridae also 
produce disulfide-rich peptide toxins (teretoxins) that are potent and specific agonists of ion channels and 
receptors of the central nervous system. Teretoxins are underexplored relative to Conus toxins, and 
represent a yet untapped pool of tools to investigate neuronal targets that are notoriously hard to 
characterize, as well as a source of therapeutic candidates for the treatment of neurological conditions.  
This work demonstrates both the application of specialized and improved solid phase peptide synthesis 
methods, and a strategy for disulfide mapping of teretoxins through the successful synthesis and 
structural characterization of the novel toxin Tv1 from Terebra variegata, the first teretoxin to be 
structurally characterized.  The second project, conducted in the laboratory of Dr. Laura Juszczak, 
focuses on expanding the utility of fluorescence spectroscopy for the study of peptides and proteins by 
developing a novel, environment-sensitive fluorophore capable of biocompatible incorporation into 
polypeptides.  Using the fluorogenic oxidative coupling reaction of 5-hydroxytryptophan and benzylamine 
which produces the fluorescent product 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI), a strategy for site-
specific, biocompatible labeling of peptides with this probe is demonstrated. Investigation of PHOXI’s 
photophysics shows that it is a potent environment-sensitive probe, making it a valuable addition to the 
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privileged class of solvatochromic fluorophores capable of probing protein structure, interactions and 
dynamics.  
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Chapter 1  - Introduction  
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 “I believe, anticipate that the chemist of the future who is interested in the structure of proteins […] will 
come to rely upon a new structural chemistry, […] and that great progress will be made, through this 
technique, in the attack, by chemical methods, on the problems of biology and medicine.” 
Linus Pauling, Nobel Lecture (11 December 1954)1 
1.1 Peptides as tools to study proteins 
 The understanding of protein structure, dynamics and interactions is central to modern structural 
biology, as underscored by Linus Pauling’s prophetic quote above1. In many ways, with the discovery and 
continued sophistication of high-resolution spectroscopic, chemical and biochemical techniques for 
probing these enigmatic macromolecules, Pauling’s predicted future has arrived. However, the immense 
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chemical and structural complexity of proteins continues to challenge even today’s chemists and 
spectroscopists. 
  One way to overcome this complexity is to work with peptides, or mini-proteins, instead. Pauling 
and Corey used just this tactic when they first described the α-helix and β-sheet as structural motifs2, 
which have since been found in innumerable proteins. Peptides as tools for structural investigation of their 
larger protein cousins offer many advantages to the experimenter, both as structural analogues of 
proteins and as simpler systems amenable to chemical modification.  
 The conception and development of solid phase peptide synthesis (SPPS) by Merrifield in 19633 
provided reliable chemical synthetic access to these molecules, and allowed their functionalization with 
chemical groups normally absent from biological systems.  In terms of structural biology and medicine, 
SPPS gave rise to three important advancements: (i) It provided synthetic access to peptidic natural 
products, (ii) allowed for the synthesis of “designer” peptides which were used as models to better 
understand protein structure and folding, and (iii) made it possible to include non-native reporter moieties 
into peptides, which enabled investigation of their structure and interaction by spectroscopic means.  
 Building on the synthetic access to peptides and versatility of their chemical modification afforded 
by SPPS, this work focuses on expanding chemical derivatization methodologies of these molecules with 
the ultimate goal of studying protein that are not amenable to traditional high-resolution structural 
techniques. In the first part of this research, improved synthetic and chemical derivatization methods are 
developed to access and characterize peptidic natural products from venomous marine snails. These 
peptides bind ion channels and receptors of the nervous system, which are transmembrane proteins that 
are notoriously difficult to investigate by high-resolution techniques such as X-ray crystallography and 
nuclear magnetic resonance spectroscopy (NMR).  The second part of the work utilizes model peptides to 
develop a novel, environment-sensitive fluorophore capable of biocompatible incorporation into 
polypeptides, and is applicable to the study of a larger subset of proteins, which may not be amenable to 
high-resolution structural methods and can not be adequately described by fluorescence spectroscopy 
utilizing intrinsic probes.  
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1.2 Marine snail venom peptides as probes of neuronal proteins 
 Ion channels and receptors are critical components of the nervous system. Characterizing the 
structure and function of these proteins not only allows for the development of pharmaceutical agents for 
neurological conditions, but also enables the mapping of neural networks, furthering the understanding of 
neuroscience as a whole. However, because these proteins are large, consist of multiple subunits, and 
span the cellular membrane, the description of their structure and function is extremely difficult using 
traditional techniques. Transmembrane proteins have both hydrophilic and hydrophobic surface exposed 
domains, making it difficult to find suitable crystallization conditions for X-ray structure determination. 
NMR analyses of these molecules are also challenging, often because of the difficulty of obtaining 
sufficient quantities of correctly folded protein during recombinant expression. Finally, attempts to 
describe their function by gene knockout methods are often inadequate, as deletion of a single gene 
coding for particular subunit interrupts the function of a whole subset of ion channels and receptors that 
contain it, resulting in a complex phenotype4. 
 One way to work around these challenges has been to use binding partners of these ion channels 
and receptors. It is possible to glean structural and functional information about these proteins, provided 
that the structure of the binding ligand is known, and that a method of tracking its interaction with the 
target exists. One source of such binding partners are venom peptides from marine snails of the 
superfamily Conoida, which produce a plethora of potent and specific modulators of ion channels and 
receptors of the nervous system to capture and immobilize their prey4.  
 From a methodology perspective, three main challenges exist in the development of conoidan 
peptide toxins for pharmaceutical and neuroscience research: gaining synthetic access, characterizing 
their structure, and describing their biological interactions with specific targets of the nervous system. 
While the venom glands of these animals are large enough to identify and elucidate the sequence of 
peptide toxins of interest using existing methods, chemical synthesis by SPPS is necessary to obtain 
sufficient material for structural and functional testing. Furthermore, the high disulfide content and size of 
some of these peptides necessitate customization and improvement of existing SPPS methodology. In 
the current work, access to larger toxin peptides utilized a number of SPPS improvements such as 
5	  
microwave-assisted coupling5, use of improved polymer solid support resins with superior swelling 
properties, and use of other techniques of preventing on-resin peptide aggregation. 
NMR is traditionally used for structure determination of these peptide toxins, but unambiguous 
structural assignment often requires isotopic enrichment, making such analyses both time-consuming and 
costly. However, owing to the high disulfide content of these peptides, additional structural detail can be 
ascertained by determination of disulfide connectivity by complementary chemical methods, thus aiding 
NMR structural assignment even without isotopic enrichment. Existing techniques for disulfide mapping of 
proteins6, which require enzymatic digestion followed by mass spectrometric analysis of the resultant 
fragments, are not applicable to conoidan toxins because these peptides often have adjacent cysteine 
residues and lack sufficient protease cleavage sites.  Instead, a technique of partial disulfide reduction 
and differential alkylation, followed by tandem mass spectrometry analysis, was adopted for this purpose 
in the current work.  
Finally, while several techniques for identifying the specific ion channels or receptors that interact 
with a particular peptide toxin exist, most are cost-prohibitive and time-consuming, and thus low 
throughput. The contemporary development of microarray technology7, which allows for rapid screening 
of thousands of compounds immobilized on a glass slide against their binding partners, promises an 
attractive alternative to existing electrophysiology and cell-based assay methods. The strategy envisioned 
in the Holford laboratory includes constructing a toxin peptide microarray. Treating the toxin microarray 
with Xenopus laveii oocytes coexpressing a fluorescent protein (a description of Xenopus oocyte 
expression system for functional studies of ion channels can be found here8) and the ion channel or 
receptor of interest would enable rapid screening of a large number of toxins against a particular target. 
Work focused on developing a heterobifunctional carbohydrate based linker that could be used for site-
specific immobilization of conoidan toxin peptides on a microarray slide without adversely affecting their 
function by way of a bioorthogonal and reversible enzymatic coupling reaction was also pursued as part 
of this dissertation project. Despite significant progress towards creation of this linker, commercially 
available peptide microarray immobilization strategies were pursued instead, therefore this project will not 
be discussed in this dissertation.  
6	  
In summary, this work demonstrates both the application of specialized and improved SPPS 
methods, and the novel strategy of disulfide mapping of conoidan toxin peptides through the successful 
synthesis and structural characterization of the novel toxin Tv1 from Terebra variegata9.  
1.3 Chemical modification of peptides for fluorescence enhancement  
The experiences gained through working with conoidan peptides have set the stage for using 
peptide chemical modification strategies to move beyond merely ion channels and receptors, and 
investigate a larger subset of proteins for which high-resolution structural techniques are either inadequate 
or impossible to implement. Complementary to structural techniques such as X-ray crystallography or 
NMR, fluorescence spectroscopy has also been used to provide valuable structural, binding, and 
dynamics data on a variety of biological systems10. It does so by measuring light absorption and emission 
characteristics of a fluorescent probe, whose singlet excited state is sensitive to the local chemical 
environment.  
In the context of protein investigations, the intrinsic fluorophore tryptophan (Trp) has been widely 
employed as a probe. Using Trp offers a number of advantages: its presence in many proteins allows for 
their investigation without any structural perturbation and proteins that lack Trp can be engineered to 
include the residue at a desired position by site-directed mutagenesis. However, Trp is far from an ideal 
fluorophore: high energy ultraviolet radiation that is required for tryptophan excitation may be damaging to 
some proteins, and is less than desirable for biological fluorescence microscopy. Also, while its 
fluorescence emission band is sensitive to the local environment, its complex photophysics often 
preclude meaningful structural interpretation of its fluorescence signal characteristics10. Furthermore, 
fluorescence analyses of proteins containing multiple Trp residues, or in the presence of exogenous Trp 
do not yield structural data because it is impossible to deconvolute signals from individual tryptophans. 
Fortunately, the utility of protein fluorescence spectroscopy has been greatly expanded by 
employing extrinsic fluorophores. In developing such probes, parallel monumental achievements have 
been made in both the rational design and synthesis of fluorophores with desirable photophysical 
properties, and in their methods of incorporation into biological molecules. Modern synthetic methods and 
powerful calculation techniques allow for rational design of fluorophores with a great variety properties. 
Concurrently, a number of protein incorporation methods have been developed, either by reactions with 
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intrinsic amino acid functional groups11, bioorthogonal coupling methods12, or incorporation of the 
fluorophore as an amino acid using amber (TAG) codon suppression techniques13. However, continued 
development in both areas is required to give access to probes that have both desirable properties and 
are amenable to a specific incorporation method.  
 While there are many probe incorporation strategies, the most desirable, and the most 
challenging introduce the fluorophore at a unique site within the target protein, use a short and rigid tether 
to do so, and do not otherwise affect the overall structure or append the target protein with exogenous 
groups or sequences. This kind of incorporation maximizes the amount of structural information that can 
be gained from a fluorescence experiment because the probe is restricted to its surrounding 
microenvironment in a known orientation14. To date, there are only two methods that can meet these 
requirements, and neither one is applicable to every protein.  
 The first is expressed protein ligation (EPL) 15,16, which allows for bioorthogonal coupling of 
peptide thioesters assembled by SPPS with a target protein containing an N-terminal cysteine residue via 
a native peptide bond. Since SPPS allows for incorporation of unnatural fluorophores by chemical 
methods, EPL can subsequently be used to append the probe bearing peptide onto a recombinantly 
synthesized protein. An obvious limitation of EPL is the requirement of a cysteine residue in favorable 
position relative to the probe site.  
 The second method relies on incorporating a fluorophore as its amino acid derivative in response 
to an unused stop codon during recombinant protein expression by chemically acylating it onto a modified 
tRNA17. This technique is extremely difficult to implement, often suffers low incorporation yields, results in 
truncated recombinant proteins, and is not necessarily compatible with any unnatural amino acids13-14. 
 In the quest to develop a fluorophore that possesses desirable photophysics and is amenable to 
site-specific incorporation, this project focuses on exploring the fluorogenic oxidative coupling reaction of 
5-hydroxytrytpohan (5HTP) and benzylamine which produces the fluorescent product 2-phenyl-6H-
oxazolo[4,5-e]indole (PHOXI) (Figure 1.2).  
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 This reaction was utilized in analytical chemistry investigations for spectrofluorometric 
determination of neurotransmitters and related metabolites containing the 5-hydroxyindole(5HI) moiety18. 
More recently, the reaction was also used to cyclize peptides containing 5HTP and a synthetic amino acid 
with a benzylamine side chain19. Although these studies did not focus on using this reaction as means of 
fluorescently tagging peptides and proteins, the reaction conditions and the few photophysical properties 
of PHOXI they identified prompted this line of inquiry in the current work.   
 From an incorporation standpoint, the PHOXI producing reaction is reported to be selective for 
5HIs, and can be conducted under aqueous mildly oxidative conditions that should not affect other 
functional groups present in peptides and proteins. Since there exist straightforward methods for 
incorporation of 5HTP into proteins20 and peptides21 (namely by selective pressure incorporation during 
recombinant expression in tryptophan auxotrophs, and through standard 9-fluorenylmethoxycarbonyl 
(Fmoc) SPPS), this chemistry could be subsequently used for site-specific labeling with PHOXI. 
Furthermore, since this reaction modifies an existing amino acid side chain, the PHOXI fluorophore would 
be located within the biomolecule in a predictable position, attached to the backbone with a single 
methylene bridge. This type of incorporation provides a complementary strategy to the inherently difficult 
amber codon and EPL based approaches.  
 From the photophysical properties standpoint, PHOXI was reported to have high brightness 
(through a combination of a high quantum yield and extinction coefficient) and emission in the visible 
range19, both desirable properties for a fluorophore reporter tag. While these properties are encouraging, 














Figure 1.2: Oxidative coupling of 5-hydroxytryptophan (5HTP) and benzylamine to produce 
2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI)
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microenvironment, Förster resonance energy transfer (FRET) interaction with intrinsic fluorophores, and 
time-resolved fluorescence properties is needed to glean its utility as a probe for biological systems.  
 The present work uses model peptides containing 5HTP to evaluate the biocompatibility and 
selectivity of PHOXI derivatization. While the reaction is selective for 5HTP, it proceeds through a highly 
reactive p-quinoneiminemethide intermediate, which is susceptible to capture by endogenous 
nucleophiles other than the intended benzylamine, resulting in a number of undesired byproducts. 
Optimization of the reaction conditions using model systems allowed for minimization of these side-
products and a high-performance liquid chromatography (HPLC) purification method was developed to 
isolate the PHOXI labeled peptides for spectroscopic and structural studies. The substrate scope of the 
reaction was also briefly investigated by using methylamine and ethanolamine in addition to benzylamine. 
While methylamine did not produce any fluorescent adducts under the conditions tested, ethanolamine 
produced three different products with fluorescence in the visible region, suggesting that a number of 
PHOXI analogues can be synthesized by varying the amine nucleophile.  
 Recombinant synthesis of proteins containing 5HTP was also attempted in hopes of evaluating 
the PHOXI derivatization reaction at the protein level. A variation on the selective pressure incorporation 
technique using standard Escherichia coli (E. coli) hosts in the presence of glyphosate (an inhibitor of 
aromatic amino acid biosynthesis), instead of the traditionally employed auxotrophic hosts was used. 
Unfortunately, attempts to synthesize two different 5HTP-containing proteins using two different 
expression systems and three bacterial host strains were not met with success. Because recombinant 
synthesis of 5HTP-containing proteins has already been demonstrated by other groups20, this was not 
pursued further, and only 5HTP peptides were used to evaluate this chemistry due to commercial 
availability and ease of handling.  
 The spectroscopic properties of PHOXI and PHOXI-labeled model peptides were also extensively 
interrogated as part of this project.  Absorption, fluorescence excitation and emission, lifetimes, and 
quantum yields of PHOXI evaluated in six neat solvents, were found to vary greatly as a function of 
solvent polarity. This sensitivity to the environment puts PHOXI in a privileged class of solvatochromic 
probes capable of interrogating the peptide/protein microenvironment.  Furthermore, PHOXI’s 
photophysics are straightforward and show more dependence on general parameters of 
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polarity/polarizability, and are less affected by specific solvent interactions that can complicate structural 
attribution of spectral data. These findings show that PHOXI’s photophysics are comparable to or better 
than those of other solvatochromic probes, such as Prodan22 or Dansyl23, that found applications in 
biological systems.  
 As in Pauling’s vision of the future, this dissertation describes the use and chemical modification 
of peptides in developing methods for structural, and functional characterization of otherwise intractable 
biological systems.  This “attack, by chemical methods” was used to describe the structure of toxin 
peptides capable of providing valuable insight into the workings of their protein binding partners; and to 
use peptides as proving ground to develop an environment-sensitive probe capable of describing an even 
larger subsection of proteins by improved fluorescence methods.  
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2.1 Toxins from venomous organisms as drug development and research tools 
Disulfide-rich venom peptide toxins found in organisms such as scorpions, snails, snakes, spiders 
and leeches are potent and specific modulators of biological targets, making them attractive targets for 
drug development and downstream research applications24. In terms of pharmaceutical applications, 
nature-inspired peptide therapeutics are gaining traction as an alternative to small molecule drugs25. 
Peptides, although not as bioavailable as small molecule drugs, have advantages of higher target 
specificity and selectivity, and decreased toxicity26. Recent successes in development of peptide 
pharmaceutics, including captopril27, and more recently Prialt®28, highlight the promise and potential of 
these compounds. Furthermore, the extraordinary affinity and specificity of these toxins contributes to 
their ability to characterize the structure and function of their biological targets. For instance, conotoxin 
GVIA, a Ca2+ channel agonist, has been used as a tool in over 2000 investigations for probing the 
molecular features of the nervous system29.  With the overall diversity of venom-derived disulfide-rich 
peptides estimated at well over two million, and with their biological targets ranging from ion channels and 
receptors, enzymes and growth factors to structural or ligand binding domains of proteins30, the potential 
of these compounds as therapeutics and research tools is only beginning to be realized.   
 2.2 Conoida mollusks as a rich source of neuroactive peptides 
Venomous marine snails belonging to the superfamily Conoida represent one source of disulfide-
rich toxin peptides. Conoidan snails are classified into three groups: cones (Conidae), terebrids 
(Terebridae), and turrids (Turridae) (Figure2.1). Among these three groups, the venom of cone snails has 
attracted the most research interest, particularly driven by the need to glean the pharmacological basis of 
human fatalities caused by Conus envenomation. 
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Conoida snails are present in tropical waters worldwide, with various species preying on fish 
(piscivorous), worms (vermivorous), or mollusks (molluscivorous). These snails are considerably slower 
than their prey, and thus had to evolve their arsenal of chemical toxins and methods for their delivery for 
the past 50 million years31. The product of this evolution is a sophisticated envenomation apparatus 
(Figure 2.2) consisting of a venom bulb, a long venom duct equipped with radular teeth which act as a 
hypodermic needle for venom delivery32. 
While the sophistication of their venom apparatus is already awe inspiring, these snails’ ability to 
produce a plethora of peptide neurotoxins with diverse biological targets rivals that of today’s best-
equipped combinatorial chemists. In fact, the genes encoding peptide toxins evolve at a much higher rate 
than housekeeping genes in these snails33.  It has been found that these peptide toxins are highly 
effective as tools for manipulating neuronal targets, including sodium (Na+), potassium (K+) and calcium 
channels (Ca2+), noradrenaline transporters, and nicotinic acetylcholine receptors (nAChRs)34. It was 
hypothesized that myriad conopeptides act in concert on the nervous system of the prey in synergistic 
“cabals”4.  The first, dubbed the “lightning-strike cabal”, leads to rapid immobilization of prey by what 
Estimated Species Diversity




Figure 2.1: Conoidan species and toxin diversity
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amounts to electrocution through slowing Na+ channel inactivation while simultaneously inhibiting K+ 
channels. The second “motor” cabal finishes the job, by using slower acting toxins to deaden neuronal 
circuits at the neuromuscular junction, producing a soporific response. Some cone snails also employ a 
third “nirvana” cabal, releasing sensory jamming peptides into the water to pacify small schools of fish 
before engulfing them with their huge false mouth in a “net” hunting strategy. While it may seem prudent 
to question the therapeutic utility of conoidan peptides, since they are supposed to bind to physiologically 
relevant targets of the snails’ natural prey (fish, worms or mollusks), these targets have a high degree of 
sequence and structural homology to their corresponding human isoforms. 
 
It is difficult to estimate the vast number of biologically active peptides that can be identified from 
Conoida snails. A typical modern venom transcriptome sequencing experiment can identify 50-100 toxin-
encoding genes in a single species35. Due to extensive post-translational processing and modification, the 
number of mature peptide toxins present in one specimen can be an order of magnitude higher. For 
example, 2428 peptide masses were identified from the venom of Conus textile36. Factors like 
A
B
Figure 2.2: Conoidan Venom Apparatus. (A) Components of the venom apparatus include the venom 
bulb, venom duct and salivary gland where toxins are produced, a sheath containing radular teeth that 
are used like hypodermic needles to deliver the toxins through the proboscis. (B) A Scanning electron 
micrograph close-up of a radular tooth, showing its harpoon-like structure and opening for venom delivery. 
Figure reproduced from reference 32.
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intraspecies, and even intraspecimen venom heterogeneity, inflate the number of putative toxins even 
further. Considering that there are about 700 known species of cone snails alone (disregarding turrids 
and terebrids), the most conservative estimate is approximately 50,000 toxin sequences at the genetic 
level, and over 1,000,000 at the peptide level. Given these numbers, the effort to identify and characterize 
these toxins has been vastly lacking in throughput with only 2837 nucleotide toxin sequences identified 
from 80 Conus species, and just 175 toxins from 34 Conus species structurally characterized37 (data from 
ConoServer accessed on 5/16/15). It is important to note that the above data represent only the toxin 
diversity and identified peptide toxins among Conus species, while the toxins of the Terebridae 
(approximately 300-400 species) and the Turridae (up to 10,000 species) remain largely unexplored. 
Specifically, this work focuses on the peptides of the Terebridae, an under-investigated sister group of the 
cones. While this group was chosen in hopes of identifying peptides with novel structures or targets, 
many descriptions of conopeptides, such as their structural and gene organization features, also hold true 
for terebrids and serve as a foundation to guide this inquiry. 
2.3 Conoidan toxin structure and function: lessons from cone snails 
The laboratories of Baldomero (Todo) Olivera, Paul Alewood and Richard Lewis pioneered the 
subject of conopeptide research, and in many ways shaped the body of knowledge in the field today 24a, 32, 
38. Early venom fractionation experiments identified two types of peptide components: disulfide poor
(such as contulakins39 and conantokins40) and disulfide-rich, termed conotoxins. These multiply 
disulfide-bonded conotoxins are the major component of the venom peptide repertoire of Conus snails, 
and target ion channels and receptors with extreme potency and selectivity. To date, conotoxins have 
been found to interact with a variety of neuronal targets, including Ca2+, Na+, K+ voltage- and ligand-gated 
channels, nAChRs, neurotensin receptors, N-methyl-D-aspartate (NMDA) receptors, norepinephrine 
transporters, and G-protein coupled receptors (GPCRs)41. With such diversity of targets, it is not 
surprising to see conotoxins as subjects of clinical trials as neuropathic pain analgesics, anti-
convulsants42, anti-cancer agents43, and cardioprotectants44; with one conotoxin (MVIA from Conus 
magus, known as Prialt® or Ziconotide) approved for the treatment of chronic and severe pain28.  
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Conoidan toxins are single gene products, with messenger RNA (mRNA) translated into a 
precursor comprised of a highly conserved signal N-terminal signal sequence, an intervening and 
somewhat more variable pre-pro region, and a C-terminal mature toxin sequence (Figure 2.3). 
 Mature conotoxin peptides, liberated by proteolysis from the signal and pre-pro regions, have a 
conserved pattern of cysteine residues and hypervariable intercysteine loops. The typical size of mature 
conoidan peptides is 10 to 60 amino acids, with at least 2 and as many as 10 cysteine residues. The 
highly conserved signal sequences are used to classify conotoxins into gene superfamilies, the pattern of 
cysteine residues into frameworks, and their biological targets into pharmacological families38b (Figure 
2.4). All mature conotoxins are post-translationally modified to contain disulfide bonds, and some have 
been found to contain a number of other post-translational modifications (PTMs), most common of which 
are C-terminal amidation, proline hydroxylation, and glutamate γ-carboxylation.  Although most of these 
PTMs are found in other species, they occur at a higher rate in these short peptides, making extensive 
PTM one of the defining features of conotoxins. The significance of PTMs in conotoxins is still being 
explored, and it has been suggested that they can play either functional or structural roles45. The roles of 
PTMs are complex and enigmatic, as they may be required for function or for the correct folding of one 
conotoxin, while having no effect on the activity or fold of another. It has been hypothesized that PTMs in 
cone snails are yet another level of refining their toxins, analogous to drug lead optimization done by 
pharmaceutical companies4.  
Signal Sequence Propeptide Mature toxin
Conserved HypervariableModerately Variable
Figure 2.3: Conoidan peptide toxin precursor organization
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2.4 The peptide toxins of the Terebridae 
Being a sister group of the cones, the Terebridae also express an arsenal of disulfide-rich 
conotoxin-like peptides (teretoxins). While there are only a few studies of terebrid venom, it is known that 
their toxins arise from mRNA with organization analogous to that of the cones, containing a signal 
sequence, pre-pro, and mature peptide regions46. Interestingly, the signal sequences of the Terebridae 
have a low degree of homology to the cones, suggesting that Conus gene superfamilies do not extend to 
the Terebridae46a. Consistent with this earlier study, a recent report identified 14 terebrid gene 
superfamilies, with only one of them having a strong (80%) sequence identity with a conotoxin 
superfamily (H)47. Although it is too early to draw any conclusions given the limited number of studies on 
the Terebridae, the disulfide-rich toxins identified so far have been longer (40 amino acids and greater) 
than Conus sequences, making teretoxins more similar to those of spiders and snakes29. While most 
conserved cysteine frameworks found in the Terebridae are the same as those found in cones, two novel 
Figure 2.4: Classification of conotoxins by gene superfamilies, cysteine frameworks and pharma-
cological families. Figure reproduced from reference  38b
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frameworks containing 10 and 12 cysteines were recently identified47. The greater length of teretoxins 
also contributes to greater numbers of residues in the intercysteine loops relative to conotoxins. Yet 
another consequence of length is the prevalence eight-cysteine (rare in cones) and the scarcity of four-
cysteine frameworks (prevalent in cones) in the toxin peptides of the Terebridae. 
The few studies conducted so far suggest that terebrid neuropeptides are free from PTMs, aside 
from C-terminal amidation 46. A recent second generation sequencing analysis of the venom duct 
transcriptome of two terebrid species, T. annilis and T. subulata, identified nucleotide sequences 
corresponding to four PTM enzymes (γ-glutamyl carboxylase, peptidyl-glycine-α-amidating 
monooxygenase, prolyl-4-hydroxylase, tyrosyl sulfotransferase and glutamyl-peptide cyclotransferase) in 
the specimens47. Although the presence of these enzymes suggests that PTMs cannot be ruled out for 
teretoxins, these proteins are quite ubiquitous across other mollusks and even mammals, and are also 
implicated in a variety of housekeeping roles. Therefore, the last word on the presence of PTMs in 
teretoxins will have to come from characterization of mature venom peptides.   
The seeming absence of PTMs in terebrid neuropeptides suggests that toxin sequences identified 
at the genetic level can be directly synthesized and investigated for their therapeutic potential with more 
confidence.  However, their extended length is anticipated to pose challenges during SPPS synthesis, the 
efficiency of which decreases with peptide length. Teretoxin synthesis by recombinant protein expression 
is one strategy that can be used to address potential SPPS challenges. 
2.5 Current approaches of conoidan toxin identification 
Early experiments aimed at identifying neuropeptide components in snail venom relied on HPLC 
venom fractionation48, followed by Edman sequencing of peptide fractions exhibiting biological activity. 
Subsequent investigations employed mass spectrometry (MS) instead of Edman degradation for 
neuropeptide sequence elucidation, which had the advantages of requiring a substantially smaller sample 
size and the ability to detect PTMs49. The lower sample requirements allowed for the identification of a 
larger number of venom components, but the throughput of whole venom fractionation was still limited 
due to difficulties in obtaining enough crude venom for complete analysis.  
Rapid advances in DNA sequencing technology have introduced a paradigm shift in snail venom 
identification practices, which now focused on identifying potential neuropeptides by analyzing the snails’ 
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venom duct transcriptome. In a typical experiment, mRNA is extracted from the specimen’s venom duct, 
and is subsequently used to construct a complimentary DNA (cDNA) library using in-vitro reverse 
transcription followed by polymerase chain reaction (PCR) amplification. The amplified cDNA fragments 
are then sequenced, and the resulting sequences are mined for defining features of disulfide-rich toxin 
transcripts: the presence of a conserved signal sequence, and multiple cysteine codons in familiar 
frameworks in the mature peptide region. The improved throughput of second generation sequencing 
technology50 allowed for analyses like these to be done at the genomic level, and further lowered the 
sample size requirements and costs of transcriptomic analyses.  
In addition to lower costs and sample size requirements, genetic identification strategies also 
allow for targeted toxin discovery33. Namely, information about signal sequences (and thus the gene 
superfamily) as well as the cysteine residue arrangement (and thus the framework) allows for selecting 
potential toxins that are inferred to be members of a particular pharmacological family. Alternatively, 
transcripts with divergent signal sequences or rare or unknown cysteine frameworks can be selected in 
hopes of identifying a novel biological target, or peptides with alternative interaction sites with traditional 
targets. Coupling this genetic toxin identification strategy with cladistic analysis, as was done in our 
laboratory for teretoxin identification, allows for a rational biodiversity guided discovery approach51.  
In spite of the advantages offered by neuropeptide identification by gene sequencing methods, it 
has drawbacks when compared to direct venom fractionation. The obvious limitation is that information 
available from genomic or transcriptomic analyses only provides the primary sequence of the target 
peptide. The native configuration of disulfide bonds cannot be obtained from such an experiment. 
Although it is sometimes possible to glean the probability of a certain PTM by the presence of a gene for 
a corresponding enzyme, it is impossible to say with certainty that this PTM will be present in mature 
peptide, or which specific residue(s) will be affected. Finally, predicting the cleavage site of the mature 
toxin from an mRNA sequence can also be difficult. Thus, although genetic level toxin identification has 
produced a number of advances, mass spectrometric interrogation of mature peptides from venom is still 
very relevant, and is often used in combination with genomic/transcriptomic data in an integrated toxin 
discovery strategy48, which offers greater insights into toxin structure, PTMs, and the native folded state. 
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Because of this continued relevance, modern advances in MS guided proteomics and de novo 
sequencing methods continue to contribute to the field of snail neuropeptide discovery. For example, the 
identification of teretoxin Tv1 from Terebra variagata (the synthesis, structural and functional 
characterization of which is described as part of this dissertation), was accomplished by using just 4ng of 
material extracted from the snail’s salivary gland by utilizing improved MS de novo sequencing methods9. 
Namely, the approach relies on using electron transfer dissociation (ETD) in addition to the ubiquitous 
collision aided dissociation (CAD) for tandem MS (MS/MS) fragmentation, which greatly improves 
sequence coverage. This method is specifically adapted to disulfide-rich toxins, because it relies on 
derivatizing cysteine residues into dimethyl lysine analogues to achieve the higher charge states required 
for ETD52. 
2.6 Current approaches to conoidan toxin synthesis 
Peptide toxins have to be chemically synthesized to afford sufficient quantities for subsequent 
structural and functional characterization. In the case of conotoxins, the preferred method is SPPS, as it 
is highly efficient for short peptide sequences, amenable to automation, and offers the flexibility of 
introducing PTMs where desired. Robust, standard SPPS protocols utilizing either tert-butoxycarbonyl 
(Boc)53 or 9-fluorenylmethoxycarbonyl (Fmoc)54 for reversible α-amino protection exist. While Boc-SPPS 
can be highly efficient at preventing on-bead peptide aggregation, it requires a specialized set-up for the 
resin cleavage step, which uses gaseous hydrogen fluoride. In contrast, Fmoc chemistry does not require 
highly specialized equipment, and although peptide aggregation can be a problem for certain sequences, 
a number of techniques have been developed to mitigate these problems. The common issues 
encountered in snail peptide SPPS are either associated with decreasing coupling and deprotection 
efficiency with increasing peptide length, or with specific sequence-level features in a given peptide. 
Some SPPS improvements to mitigate these issues include: engineering of solid supports with better 
swelling properties in solvents of varying polarity55, design of more efficient coupling agents56, 
aggregation-disrupting pseudoproline backbone protection57, dipeptide coupling to prevent aspartimide 
formation58, and microwave-assisted coupling5. The synthetic utility of SPPS is further increased to longer 
peptides and proteins when it is coupled with bioconjugation methods such as native chemical ligation 
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(NCL)59, a chemoselective joining of a peptide thioester with an N-terminal cysteine containing peptide 
resulting in a native peptide bond. 
 Although longer peptide sequences of the Terebridae could be accessed with SPPS with the 
aforementioned improvements, their presumed lack of PTMs also makes them amenable to biosynthesis 
through recombinant expression. While cheaper than SPPS, recombinant expression is not usually used 
for the synthesis of peptides, which tend to be unstable in common host organisms such as E. Coli. As a 
workaround solution, peptides can be expressed as a fusion construct by appending their sequence onto 
that of a protein that has good cytosolic solubility and high expression levels in the host60. By engineering 
a specific protease cleavage site between the neuropeptide and fusion protein partner coding regions, it 
is possible to obtain the peptide of interest without any exogenous sequences.  
 After synthesis by either SPPS or recombinant expression, formation of disulfide bonds is 
accomplished by a variety of oxidative folding protocols. While during SPPS peptides are always initially 
formed in the linear (reduced) form, recombinant expression may produce a peptide with preformed 
disulfides. While the latter case is unlikely in the common host E. coli because it has a reducing cytosol, it 
is possible if a different host organism or specialized strain is used. Even if disulfides are formed during 
recombinant expression, the peptide may still need to be subjected to reduction and refolding because 
the disulfides formed in the host organism can be in a non-native arrangement. 
  Oxidative folding strategies for peptides containing multiple disulfides can be broadly classified 
into two groups:  random oxidative folding of fully deprotected peptides, and directed regioselective 
disulfide bond formation (Figure2.5)61. During random folding, the fully deprotected peptide is dissolved in 
a slightly alkaline buffer at high dilution (to prevent dimer and oligomer formation) and mild oxidizing 
agents such as N,N-dimethylsulfoxide (DMSO) or thiol exchange reagents (such as a mixture of oxidized 
and reduced glutathione) are added to facilitate disulfide bond formation. Polymer supported oxidizing 
agents, such as ClearOx(cross-linked ethoxylate acrylate resin loaded with Ellman’s reagent) have also 
been used for conotoxin folding62, and provide the advantage of conducting folding reactions in reduced 
volumes of buffer because of a pseudodilution effect. While cheap and easy to implement, random folding 
is complicated by the number of disulfide bonds to be formed due to the number of possible isomers, 
(2n)!/(2nn!) where n is the number of disulfides, that can arise during the process. 
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Although the presence of thiol exchange reagents attempts to mimic physiological folding 
conditions allowing disulfides to reshuffle and direct the fold to the most thermodynamically stable 
conformation, low yields can be observed due to formation of a number of kinetically trapped isomers 
(Figure 2.6). Furthermore, the predominant isomer formed during random folding may not be the same as 
the native form, since in the snails disulfides are formed during post-translational processing prior to 
cleavage of the signal sequence and pre-pro regions, which aid in the recruitment of protein disulfide 
isomerase (PDI) that in turn facilitates folding61. Nevertheless, non-native disulfide-bond isomers may be 
active analogues with interesting pharmacological properties, thus they can also be of interest. Random 
folding experiments can be optimized by HPLC monitoring of reaction products while varying the reaction 
temperature, time, peptide and thiol exchange reagent concentrations, as well as buffer salt content.  
One-Step Regioselective
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Figure 2.5: One-step and regioselective folding strategies for disulfide-rich peptides
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Alternatively, if the disulfide arrangement of the toxin peptide is known, directed regioselective 
folding could be employed to obtain only the desired isomer (Figure 2.5, right). In this approach, pairs of 
cysteine residues that are known to form disulfides in the native toxin, are differentially protected during 
SPPS.  Following synthesis, the fully protected peptide is cleaved from the resin, and disulfides are 
formed sequentially by selective deprotection of pairs of cysteines and subsequent stepwise oxidation. 
Global deprotection takes place after all disulfides have been formed, and care must be taken to avoid 
thiol reshuffling during this step. For peptides containing more than three disulfides, a semi-directed 
approach can also be employed. Specifically, one disulfide is formed in a directed fashion, the peptide is 
fully deprotected, and the remaining disulfides are formed by random oxidation. The conformational 
restriction introduced by the pre-formed disulfide bridge directs the correct configuration of the remaining 
disulfides. Alternatively, directed folding can be accomplished prior to cleavage of the peptide from the 
solid support. This approach is attractive from a throughput standpoint because of its applicability to the 
synthesis of combinatorial peptide libraries, but still faces a number of technical issues38b. Thus, although 
some conotoxins were successfully made by on-resin oxidation, their folding yields in solution were 
better63. Finally, directed folding can also be achieved without the need for differential cysteine protection 
by utilizing selenocysteine64. Selenocysteine has a lower redox potential and a lower pKa than cysteine, 
allowing for the diselenide bridge to be formed selectively, followed by disulfides. In context of the current 
project, random folding is employed for the synthesis of teretoxins, because their native disulfide 
configuration is unknown.  
Figure 2.6: Kinetically trapped intermediates in in-vitro folding reactions. A. HPLC trace and free 
energy funnel representation of a folding reaction showing kinetically trapped intermediates. B. HPLC 
trace and free energy funnel representation of a folding reaction with no kinetically trapped intermediates
A B
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2.7 Structural characterization of Conoidan toxins. 
NMR spectroscopy has been the technique of choice for conotoxin characterization. While difficult 
to crystallize, structural studies of these small and rigid peptides can often be accomplished by 
homonuclear NMR without the need for isotopic labeling. However, NMR structural assignment still 
requires a substantial amount of sample, and may be more difficult to implement for the larger toxins of 
the Terebridae. Owing to the highly disulfide-bonded nature of these molecules, an alternative approach 
relying on disulfide mapping followed by molecular dynamics (with explicit disulfide bridges) simulation 
can be envisioned, and is developed in this work. Classic disulfide mapping in proteins is accomplished 
by protease (usually trypsin) digestion, followed by mass spectrometric analyses of the peptide fragments 
before and after complete reduction. Unfortunately, this is not very applicable to Conoidan peptides 
because they lack sufficient protease sites and often contain adjacent cysteine residues. An alternative 
disulfide mapping technique relies on partial reduction of disulfides followed by differential alkylation of 
pairs of liberated cysteines. Edman sequencing of the fully reduced and differentially alkylated peptide 
leads to disulfide assignment. In this work, the partial reduction and differential alkylation method is 
utilized, but the analysis of the resulting differentially alkylated peptide is accomplished by tandem mass 
spectrometry by adapting recently described methods 65, which dramatically reduce sample requirements 
and costs. 
2.8 Current approaches to conoidan toxin functional characterization 
 Initial biological activity characterization of Conoidan toxins is traditionally accomplished by 
means of phenotypic assays, such as by intracranial injection of a putative peptide toxin into mice66, or 
typical snail prey organisms such as Caenorhabditis elegans (C. elegans)46a. The phenotypic response 
observed during this initial screening, is only indicative of general toxin function. Further attribution of 
peptide toxin activity to a specific neuronal target is accomplished by means of electrophysiological 
recordings utilizing voltage- or patch-clamp techniques67. In this realm, ex-vivo tissue preparations with 
extensively characterized ion channel and receptor distributions, such as mammalian dorsal root ganglion 
(DRG) neurons68, or HEK cell lines69 have found numerous uses in the field of conotoxin research.  
 One extensively used method for electrophysiological characterization of Conoidan toxin 
bioactivity relies on the use of oocytes of the African frog, Xenopus laevis as a model system8. Devoid of 
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endogenous ion channels, these large progenitor cells are engineered to express a specific ion channel 
or receptor subtype by injecting them with genetic material (mRNA) coding for this specific target. 
Heterologous expression of ion channels and receptors of interest in HEK cells have also been shown69. 
Subsequent electrophysiological recordings in the presence and absence of a putative peptide toxin, are 
used to not only delineate the toxin’s specific neuronal target but also the mode of their interaction (i.e. 
activation, deactivation etc).  
While electrophysiological recordings provide functional information in excess of merely 
identifying the specific ion channel being targeted, these methods suffer from low throughput. Efforts to 
increase the throughput of these techniques include automated parallel electrophysiology platforms, the 
use of fluorescent reporters sensitive to ion concentration, and ion flux assays70.  As an alternative, 
binding assays utilizing radioactive or fluorescent tracers can be used to screen for biological activity of 
conoidan peptides in a high-throughput manner, albeit without functional modality information.   
2.9 Objectives of Thesis Project 
The Holford laboratory focuses on adapting the techniques used in identification, synthesis, 
structural and functional characterization of conotoxins to the neuropeptides of the Terebridae, a sister 
group to the cones, to expand the existing pool of marine peptide natural products. While adapting 
existing methods to these underexplored animals promises the discovery of peptides with novel neuronal 
targets and modes of action, the methodology developed also attempts to address challenges of 
throughput associated with disulfide-rich peptide discovery and characterization as a whole.  
As a chemist in the lab, I was tasked with synthesis and structural characterization of terebrid 
neuropeptides, as well as with chemical aspects of creating a high-throughput microarray based assay to 
screen teretoxins against their biological targets. Specifically, the research objectives were: 
1. Synthesis and oxidative folding of novel terebrid neuropeptides, utilizing modern SPPS and/or 
recombinant synthesis strategies. Fmoc-SPPS procedures for manual and microwave-assisted synthesis 
procedures were developed and implemented for the synthesis of teretoxins in Table 2.1. For the peptide 
Tg77, a fusion-protein recombinant expression system was designed as part of this dissertation project, 
and was subsequently implemented by Mary E. Wright, a biochemistry graduate student in our lab.  
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Three of these peptides, Tg03, Tv1, and Arg58 were successfully assembled by Fmoc-SPPS. Random 
oxidative folding optimization experiments on Tv1 and Arg58 were also carried out. The Fmoc-SPPS, 
recombinant synthesis, and oxidative folding protocols that were adapted to teretoxins as part of this 
dissertation project, are in continued use in the Holford laboratory.  
Table 2.1: Teretoxin neuropeptides identified for synthesis  
Peptide	   Sequence Identified From 
Tg55 TACEQHTDCSAASGPKYCCQDSDCCGGTEYICTNY
GQCLRSFGGRNDIFHLRLSRLTHRMKK (62AA) 
T. guttata cDNA 
Tg03 SECETDDDCDIDQCCVEDTYFSSEWINVCSTCD 
(33AA) 
T. guttata cDNA 
Tg77 SLTEKAGGCPLYCSSQIFCCHGRKCRNVDGRLKCV
TEASMLGK (44AA) 
T. guttata cDNA 
Tv1 TR(I/L)CCGCYWNGSKDVCSQSCC (21AA) T. variagata salivary 
gland MS de novo 
sequence 
Arg58 PDICDGCPYKRGGDCCDLDIECC (23AA) T. argyosia cDNA 
 
2. Structural characterization of synthesized teretoxins by adapting a disulfide mapping technique based 
on partial reduction, differential alkylation and tandem MS analysis. Optimization of differential alkylation 
conditions and adaptation of ultra-high pressure liquid chromatography (UHPLC) methods resulted in the 
successful disulfide mapping of Tv1, a teretoxin shown to induce a phenotypic response upon injection in 
to polychaete worms. Analysis of MS/MS data, which contributed to the assignment, was done in 
collaboration with Dr. Vadi Bhatt from Agilent technologies.  
.  
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3.1 Teretoxins: from identification to synthesis and characterization 
Conoidan peptides are attractive targets for pharmaceutical and neuroscience research 
applications. In a quest for identifying compounds with novel biological targets, as well as to enrich the 
peptide marine natural product pipeline in general, the Holford laboratory is focused on the study of the 
venom peptides of the Terebridae, a sister group to the cones, whose toxins are much more well known. 
This laboratory has been exceedingly successful in identifying putative peptide toxins from terebrid 
species, in part through implementing a biodiversity-guided rational discovery method, dubbed the 
“concerted discovery strategy” (Figure3.1)71. Instead of randomly selecting specimens for mining peptide 
toxin sequences, the strategy relies on the use of taxonomic tools for phylogenetic analysis, which in turn 
allows identification of potential toxins from divergent lineages, thus maximizing diversity of lead peptides. 
Correlating phylogenetic information with the anatomy of the Terebridae allowed for identification of 
several lineages that have lost their venom apparatus, and thus helped refocus toxin discovery efforts 
only on the clades that retained this anatomical feature. The application of this strategy has resulted in 
myriad cDNA transcripts of putative toxins identified from terebrid species, several of which were selected 
for further investigation. Through work with collaborators, who focus on improving de novo mass 
spectrometric sequencing methods of disulfide-rich peptide toxins52, terebrid toxins were also identified 
from crude venom.  
While identification of putative toxins is an important step in the development process, chemical 
synthesis is required for sufficient quantities of the peptide toxins to be available for functional assays. 
Additionally, structural characterization of biologically active terebrid neuropeptides is needed to delineate 
the structure-activity relationships with their targets. This part of the dissertation project focuses on 
chemical synthesis of putative toxins of the Terebridae identified by the Holford lab and collaborators, as 
well as their structural characterization. Numerous studies of disulfide-rich venom peptides of cone snails, 
serve as a general guide for the workflow of synthesis, oxidative folding and structural characterization of 
terebrid peptides. While adapting these existing techniques to teretoxins is itself a challenge, 
improvements in throughput during these stages of the toxin development process are also needed. This 
bottleneck in throughput in the synthesis and characterization stages is particularly evident in examining 
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ConoServer data, with 2837 toxin sequences identified and only 175 characterized (ConoServer 
accessed on 5/16/15)37. 
 
Figure 3.1:Traditional and concerted discovery strategies for teretoxins. A. Traditional strategy. 
Analyzed species are chosen randomly, and may correspond to a single lineage. Prospective toxin 
analysis starts first with characterization of venom components by HPLC (venom fractionation). B. 
Concerted Discovery Strategy (CDS). Taxonomic tools are used first to identify independent lineages to 
maximize the species, and thus teretoxin diversity, and then to analyze the numerous cDNA compounds 
isolated from each analyzed specimen. Application of CDS increases discovery of divergent teretoxins. 
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SPPS is the conotoxin synthesis strategy of choice, particularly efficient for their short sequences, 
and amenable to installation of a variety of PTMs encountered in these peptides. The longer peptide 
toxins of the Terebridae push the limits of this strategy, necessitating special improvements to the 
process. The apparent lack of PTMs in teretoxins, however, makes it possible to synthesize these toxins 
recombinantly. SPPS protocols adapted to sequence features and lengths of specific teretoxins are 
developed in this work. Particularly, microwave-assisted automated synthesis is used to combat 
inefficiency of SPPS of longer peptides, as well as to improve throughput. A recombinant expression 
strategy for the cost-effective synthesis of longer teretoxins is also designed as part of this project.  
 Correct formation of intramolecular disulfides in conoidan toxins is key to their activity. Decades 
of conotoxin research identify a number of oxidative folding protocols, both random and regioselective, for 
this purpose. Due to the nature of techniques used to identify teretoxin sequences in our laboratory, there 
is no information about their native disulfide connectivity. Therefore, random oxidative folding procedures 
are used for the teretoxins synthesized for this thesis work. A variety of folding conditions are evaluated to 
maximize the yield of the desired bioactive isomer. 
NMR is traditionally used for structural characterization of conotoxins. Their small size and highly 
disulfide-bonded rigid structure make NMR structural assignment of conotoxins possible often even 
without isotopic labeling. However, NMR analyses still have high sample requirements, and the larger 
peptides of the Terebridae may necessitate costly isotopic enrichment for unambiguous structure 
determination. Instead, this work focuses on developing a mass spectrometric approach for the disulfide 
mapping of teretoxins, as means of their structural characterization.  
Traditionally, HPLC is used throughout synthesis, oxidative folding, and disulfide mapping of 
peptide toxins, to ascertain SPPS yields and side products, monitor progress of folding reactions, and 
separate partially reduced peptide species. In this work, the newly developed ultra high-pressure liquid 
chromatography (UHPLC)72, is adapted for these purposes. This technique offers greatly shortened 
analysis time, as well as reduced solvent requirements relative to traditional HPLC. Adapting UHPLC for 
the development of teretoxins demonstrates another way to improve the throughput of synthesis and 
characterization stages of peptidic marine natural product development.  
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3.2 Results and Discussion 
Terebrid neuropeptide sequences selected for development are listed in Table 3.1, along with 
methods chosen for their synthesis, and successfully completed development stages. Fmoc SPPS was 
chosen for production of peptides Tg55, Tg03, Tv1 and Arg58. 
 
In straight chain synthesis, peptides are assembled from the carboxy (C) to amino (N) terminus, 
by successive couplings of activated esters of Nα-Fmoc protected amino acids onto a solid support 
(Figure 3.2). Fmoc amino acids are routinely activated by O-Benzotriazole-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate (HBTU) in the presence of diisopropylethylamine (DIPEA) for coupling, and 
deprotected with 20% piperidine in DMF. Reactive side chain functionalities of the Fmoc amino acid 
building blocks are protected with standard acid-labile groups. When the target sequence is reached, the 
peptide is fully deprotected and cleaved from resin by a cocktail of trifluoroacetic acid (TFA) and 
scavengers. Manual SPPS was initially used in attempts to synthesize Tg55, Tg03, as well as to establish 
general protocols for syntheses of terebrid neuropeptides. Using the manual SPPS methods as a guide, 
syntheses of Tv1 and Arg58 were completed by an automated microwave peptide synthesizer. During 
manual synthesis, the ninhydrin test for free amines is used to assess the efficiencies of coupling and 
deprotection reactions, while in automated synthesis, the waste stream from the deprotection reaction is 
analyzed spectrophotometrically for the UV-absorbing Fmoc group.  
Table 3.1: Teretoxin neuropeptides identified for development


































































































For peptides made by SPPS, double-coupled residues are in bold. Tg55 sequence highlighted in red was to be assembled as a peptide 
thioester for subsequent NCL.Underlined sequence DG was introduced as a dipeptide. 
	  
































































Figure 3.2: Straight chain Fmoc SPPS diagram
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Information from these assessments is then used for synthesis optimization by using a longer coupling 
time, more effective coupling reagent, or double-coupling (repeating a coupling reaction) a specific amino 
acid. 
Attempts at synthesizing Tg55 by manual Fmoc SPPS were severely hampered by decreasing 
coupling efficiency with increasing peptide length. However, its C-terminal fragment Tg55(31-62), bearing 
an N-terminal cysteine was successfully assembled, suggesting a possible strategy of assembling Tg55 
from two SPPS prepared halves joined through NCL (Figure 3.3).  
 
In this approach, a peptide thioster fragment is joined to another fragment containing an N-terminal 


































































Figure 3.3: Tg55 convergent synthesis by SPPS and NCL
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Tg55(1-30), was to be assembled on a sulfamylbutyryl “safety catch” resin73, which allows the generation 
of peptide thioesters on the solid phase, via activation of the linker with trimethylsilyldiazomethane 
(TMS-CH2N2) after standard SPPS, and cleavage of the peptide by nucleophilic displacement with a thiol. 
Both fully deprotected Tg55 fragments are then joined by NCL in the presence of thiols under mildly 
denaturing aqueous conditions. However, repeated attempts to generate the peptide thioester Tg55(1-30) 
were unsuccessful, due to inefficiency of loading the slufamylbutyryl “safety catch” resin. The difficulty of 
loading this resin, as well as cleavage of thioesters from it is well documented74, and despite using the 
chaotropic salt LiBr, which was proven to enhance resin swelling and aid in loading reactions onto the 
sylfamylbutyryl linker75, no thioester cleavage products were observed during repeated test cleavages of 
Tg55 peptide fragments from this resin. Due to these difficulties, its synthesis was not pursued further. 
Manual synthesis of the peptide Tg03 successfully resulted in a product corresponding to the 
calculated mass of the peptide. However, this peptide’s extremely low isoelectric point, resultant from 11 
acidic residues within its sequence, made it difficult to handle, particularly during HPLC purification. 
Because of general problems of solubility of this peptide, and its incompatibility with HPLC buffers, its 
oxidative folding and structural characterization was not pursued. 
Both Tv1 and Arg58 were successfully synthesized by automated microwave-assisted Fmoc 
SPPS. Due to inherent uncertainty in the MS derived de novo sequence, both Leu3 and Ile3 homologs of 
Tv1 were assembled for subsequent oxidative folding and structural characterization.  
A recombinant synthesis strategy, including choice of vector, solubilizing protein fusion tag, host 
organism allowing for disulfide bond formation, and protease cleavage site to afford the native peptide 
without exogenous sequences was designed (Figure 3.4). In addition to being optimized for efficient 
production of disulfide-rich peptides, this strategy also uses ligation-independent cloning (LIC)76, a time 
and cost saving measure. LIC eliminates the need of treating an expression vector and insert with 
restriction endonucleases, dephosphorylating the vector, using DNA ligase, and all of the associated DNA 
purification steps.  Instead, LIC uses the proofreading function of DNA polymerase to create long (10-
12bp) complimentary overhangs during PCR in the absence of a single deoxyribonucleotide phosphate. 
The insert is simply added to the linearized vector with complimentary 10-12bp overhangs, and this 
mixture is used directly to transform competent host cells, without the need for DNA ligation.  The 
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implementation of this recombinant synthesis strategy by a biochemistry graduate student, Mary E. 
Wright, resulted in successful synthesis of Tg7777.  
As teretoxins contain multiple cysteine residues, their oxidative folding into the biologically active 
conformation may at times be challenging. Synthetic peptide toxins are folded in solution by employing 
various oxidizing agents. However, because there are multiple arrangements of disulfide bonds, the 
formation of biologically inactive, kinetically trapped folding intermediates is possible.  To avoid this, many 
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folding reaction conditions must be evaluated. In the folding of Tv1 and Arg58, dimethylsulfoxide (DMSO), 
mixtures of oxidized and reduced glutathione (GSH:GSSG), and ClearOX (immobilized Ellman’s reagent) 
were all evaluated as oxidizing agents. The best results were obtained with GSH:GSSG mixtures, and the 
folding yields of Tv1 were further optimized for maximal yield of the active folded product by varying the 
reaction time, temperature, pH, and salt concentration. Arg58 folding was not optimized further because 
no functional activity was confirmed for any of its folded products. Functional testing of Arg58 is ongoing 
in the Holford laboratory.  
Following confirmation of its biological activity in a phenotypic assay in polychaete worms, 
disulfide mapping of Tv1 was accomplished by a strategy of partial reduction and differential alkylation 
coupled with MS/MS analyses (Figure 3.5). A similar strategy, utilizing UHPLC and nanoflow LC-MS was 
successfully used for disulfide mapping using just picomols of sample78. This method is well suited for 
teretoxins as many of them have an inadequate number of protease cleavage sights, barring the 
traditional protease digest and MS approach. In this strategy the folded neuropeptide is first partially 
reduced at low pH using TCEP. The partially reduced species are then separated by RP-HPLC, and 
immediately alkylated with n-ethylmaleimide (NEM) at low pH. Excess NEM is removed by desalting. 
Keeping the pH low during these steps is crucial in preventing disulfide scrambling. The remaining 
disulfides of each partially reduced conformation are then reduced completely and either alkylated with 
Iodoacetamide (IAM) or left as free sulfhydrils. Following a final desalting, the partially reduced and 
differentially alkylated species are subjected to MS/MS. Upon entering the collision chamber of the mass 
spectrometer, the peptides break along the backbone producing characteristic N-terminal b, and C-
terminal y ions. Analysis of b and y ions of each partially reduced and alkylated species, yields 
information on one disulfide bond connectivity. Thus, for the disulfide mapping of a peptide containing 
three disulfide bonds, it is necessary to analyze at least two non-redundant partially reduced and 
alkylated species to assign the framework. All six possible partially reduced Tv1 species were 
successfully resolved, differentially alkylated, and provided non-conflicting information on its disulfide 
connectivity. This disulfide assignment was further confirmed by solution 1H NMR of Tv1. 
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3.2.1 Synthesis of selected terebrid neuropeptides 
Manual solid phase peptide synthesis of Tg55 proceed relatively smoothly through Phe42, 
although bulky amino acids had to be double-coupled (double-coupled residues are shown in bold in 
Table 3.1). After Phe42, decreased coupling and deprotection efficiency, as ascertained by the ninhydrin 





















































































of partially reduced peptides
Figure 3.5: Partial reduction, differential alkylation, and MS/MS analysis for disulfide mapping of 
teretoxins. For simplicity, the scheme is shown on a peptide with two disulfides 
38	  
deletion products with acetic anhydride. Despite considerable efforts, deletion products and truncated 
peptides dominate the HPLC spectrum of Tg55(32-62), with a marked increase in these unwanted 
species observed relative to the fragment Tg55(47-62) (Figure 3.6). Although the presence of Tg55(32-
62) among the many cleavage products was confirmed by MS, its purification was not immediately
attempted because easier separation was envisioned after NCL with Tg55(1-31) thioester. Unfortunately, 
repeated attempts to synthesize the Tg55(1-31) thioester fragment were unsuccessful, and SPPS 
synthesis of Tg55 was not pursued further.  
Tg03 was successfully assembled by manual SPPS, as confirmed by mass spectrometry (Data 
not shown). However, its low isoelectric point conferred very low solubility in acidic HPLC buffers. 
Attempts to use basic HPLC buffers were complicated by decreased column performance at high pH. 
Due to these solubility and handling problems, the development of Tg03 was not pursued further. 
Arg58 was successfully synthesized by automated microwave-assisted SPPS. Previous attempts 
at manual synthesis of this peptide have identified sequence regions that suffer from low coupling 
efficiency. Utilizing this information, selected residues were programmed to be double-coupled during 
automated SPPS. To further minimize unwanted side products, the aspartimide formation prone 
sequence Asp-Gly (underlined in Table 3.1) was introduced as a backbone dimethoxybenzyl (dmb) 
A
B
Figure 3.6: HPLC monitoring of SPPS cleavage products of Tg55. A.Cleavage of Tg55(47-62), a 
26mer, peak at 20.015min corresponds to desired peptide. B. Cleavage of Tg55(32-62), a 31mer, peak at 
21.520min corresponds to desired peptide.
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protected dipeptide and double-coupled.  Figure 3.7 shows the UHPLC traces of purified Arg58, and its 
mass spectrum. 
 
 Both Leu3 and Ile3 variants of Tv1 were successfully assembled by automated microwave-
assisted SPPS. Double coupling of the first three residues was used to improve synthetic efficiency, using 
information from prior synthesis attempts. The HPLC and MS of Tv1 are shown in Figure 3.8. 
Furthermore, the MS/MS spectrum of synthetic Tv1 is practically identical to that of native Tv1 (Figure 
3.9), confirming the validity of its de novo sequence assignment. Both Leu3 and Ile3 were used in 
subsequent folding, functional and structural experiments, but behaved nearly identically. For 
convenience, only Tv1(Ile3) data is shown in subsequent sections. 
A
B
Figure 3.7: UHPLC and MS of synthesized Arg58. A. UHPLC trace showing the desired peptide 
denoted with an asterisk. B. MALDI-TOF spectrum of synthesized Arg58 showing [M+H] 2494.46, 
calculated mass is 2493.85
	  




Figure 3.8: UHPLC and MS of synthesized Tv1: A . UHPLC trace of purified syntheticTv1. B. MAL-
DI-TOF spectrum of synthesized Tv1 showing [M+H] 2316.32, calculated mass is 2316.87
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The peptide Tg77 was successfully produced recombinantly, following a strategy developed as 
part of this dissertation project. Figure 3.10 shows the production of Tg77-GST fusion protein during 
expression in E. coli Origami B, and Figure 3.11 shows the cleavage of mature Tg77 by enterokinase. 
After optimization of enterokinase cleavage conditions, a yield of 2.5mg Tg77/L of culture was obtained. 
MS analysis of recombinant Tg77 shows that the peptide has been produced in a folded state, consistent 
with a reduction of mass associated with a loss of 6 protons during the formation of 3 disulfides. 
Figure 3.9: ETD spectra of native (black) and synthetic Tv1 (blue). MS/MS spectrum recorded on a 
(M + 6H)+6 ion after conversion of cysteine residues to dimethyl lysine analogs. The sequence is given 
above the spectrum and observed c and z-type fragment ions are indicated in the sequence. The spec-
trum was recorded at a resolution of 7500 at m/z 400 and all fragment ions have a mass accuracy of 
better than 5 ppm. 
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Figure 3.10: SDS-PAGE analysis of expression and purification of Tg77 fusion protein. M - protein 
molecular weight marker. Lane 1 - Tg77 crude lysate. Lane 2 - Tg77 crude lysate after binding to 
nickel-NTA resin. Lanes 3,4 - washing steps. Lane 5 - purified Tg77 fusion protein. Figure reproduced 
from reference 77
Figure 3.11: HPLC monitoring of enterokinase cleavage and LC-MS of recombinantly produced 
Tg77. A. Semi-preparative HPLC of folded Tg77. B. LC-MS characterization of folded Tg77 (expected 
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3.2.2 Oxidative folding of terebrid neuropeptides Tv1 and Arg58 
Both Tv1 and Arg58 were folded using 10:1 GSH:GSSG as the oxidizing agent. UHPLC 
monitoring of folding reactions allowed for rapid screening of a variety of folding conditions.  UHPLC 
monitoring of Tv1 over time, shows production of predominantly a single isomer within 2 hours (Figure 
3.12). The effect of temperature, pH, and salt concentration on folding yields of this isomer of Tv1, 
measured as %area of this peak (UV detection of HPLC folded products at 229nm), were investigated 
(Figure 3.13). The optimal conditions for Tv1 folding were after incubation for 4 hours at 4°C (20µM Tv1, 
1.0M NaCl, 0.1M Tris, 0.1mM ethylenediaminetetraacetic acid (EDTA), 10mM GSH, 1mM GSSG), with 
over 90% yield of the desired isomer. Figure 3.14 shows the UHPLC trace, and MS confirmation of the 
biologically active folding product of Tv1 purified to 99%.  
 
Figure 3.12: UHPLC monitoring of oxidative folding of Tv1 over time. 20μM Tv1 in 0.1M Tris pH 7.4, 
0.1mM EDTA, 1M NaCl, 10mM GSH and 1mM GSSG. UHPLC UV detection at 229nm. 
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Figure 3.13: Optimization of oxidative folding of Tv1. Y-axis represents the yield of biologically active 
folding product of Tv1 as ascertained by UHPLC with UV detection at 229nm. 20�M Tv1, 0.1M Tris, 
0.1mM EDTA, 10mM GSH and 1mM GSSG. +salt indicates addition of 1M NaCl.
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 Arg 58 folding resulted in approximately 60% yield of one isomer (Figure 3.15). Biological activity 
testing of this isomer, as well as four other isolated minor folding products of Arg58 did not indicate 
activity, presumably due to limitations of the assays employed. Additional functional testing of folding 
products of Arg58 using alternative methodologies is ongoing, and further folding optimization and 
structural characterization of this peptide is reserved until confirmation of biological activity.  
Figure 3.14: UHPLC and MALDI-TOF analysis of purified folded Tv1. A. UHPLC trace of folded Tv1 





3.2.3 Structural characterization of Tv1: disulfide mapping by partial reduction, differential alkylation and 
MS/MS analysis 
The major folding product of Tv1 obtained using optimized conditions, isolated and purified to 98% using 
semi-preparative HPLC, was subjected to partial reduction by tris-carboxyethylphosphine (TCEP) in 
citrate buffer pH 3.0. The reaction time and TCEP concentration was evaluated by direct injection of 
reaction contents onto UHPLC column, and analyzing partially reduced products. All six possible partially 
reduced species were observed upon optimization of reaction conditions (Figure 3.16). The UHPLC 
method was then transferred to an HPLC platform to allow for manual collection of partially reduced Tv1 
products. Upon HPLC separation, the six partially reduced species were collected directly into tubes 
containing an NEM alkylating solution (pH 3.0). Following alkylation, excess NEM reagent was removed 
Figure 3.15: UHPLC and MALDI-TOF analysis of folded Arg58. A. UHPLC trace of Arg58 folding 
products. Major product is denoted with an asterisk . B. MALDI-TOF spectrum of Arg58 major folding 




by a UHPLC desalting protocol. The desalted, NEM alkylated species were then reduced completely by 
incubation with 100mM TCEP, and alkylated with IAM. The resulting species, labeled with two, four, or six 
NEM and/or IAM groups were once again desalted using UHPLC, lyophilized, and subjected to LC-
MS/MS to determine NEM and IAM alkylation sites by matching the MS/MS data to b- and y- series ions 
to theoretical patterns. These analyses of all six differentially alkylated species provided complimentary 
and non-contradictory information, resulting in the connectivity assignment: Cys4-Cys20, Cys5-Cys21, 
and Cys7-Cys16 (Table 3.2).  
Table 3.2. Predicted and observed of b and y ions of differentially alkylated peptides by auto and 
targeted MS/MS analysis 








MS/MS	  for	  precursor	  ion-­‐m/z	  932.026	  (+3)	  of	  parent	  ion	  2793.0552	  
TRIC b4 474.2493	   599.2902 599.297 125.0414 NEM 
TRICC b5 577.2585	   759.3197 759.3276 125.0414+57.0198 NEM+IAM 
C y1 122.0270 179.048 179.0485 57.021 IAM 
CC y2 225.0362 407.1048 407.1054 57.021+125.0476 IAM+NEM 
CCSQSC y6 630.1680 869.2579 869.2586 57.021+125.0476+125.0479 IAM+2NEM 
MS/MS	  for	  precursor	  ion-­‐m/z	  977.376	  (+3)	  of	  parent	  ion	  2929.1027	  
TRICCG b6 634.2800 884.3632 884.3753 250.0832 2NEM 
TRICCGC b7 737.2891 1044.4083 1044.406 307.1192(250.0831+57.036) 2NEM+IAM 
C y1 122.0270 247.0747 247.0747 125.0477 NEM 
CC y2 225.0362 475.1292 475.1316 250.093 2NEM 
CCSQSC y6 630.1680 937.2707 937.2849 57.0188+250.0859 IAM+2NEM 
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This connectivity was also confirmed by an NMR solution structure of Tv1, obtained by collaborators 
Mohammed Bhuiyan and Sébastien Poget (Figure 3.17). Despite having a cysteine scaffold similar to 
M-superfamily conotoxins, the disulfide connectivity of Tv1 has not been previously observed in Conus 
Peptides79. 
 
Figure 3.16: UHPLC analysis of partially reduced Tv1 peptide on a UPLC (BEH 300 C18 1.7µm, 
Waters Corporation, Milford, MA, USA) column, a linear gradient of 0-75% buffer B (80% acetonitrile, 
0.1% TFA) in buffer A (0.1% TFA) over 6 minutes and peaks were assigned by their degree of reduction. 
Labels indicate how many disulfides are present.
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Figure 3.17: NMR confirmation of Tv1 disulfide assignment. A. NOE contacts confirming the C7-C16 
disulfide bond. An overlay of the HNHα fingerprint region of the NOESY (in black) and TOCSY (in blue) 
spectra shows NOE crosspeaks linking Cys 16 and Cys 7 as well as contacts in the residues flanking the 
C7-C16 disulfide bond (C7-S17,  Y8-C16, G6-C16, G6-N18). B. An overlay of a cartoon representation 
and a stick model of the lowest-energy structure of Tv1 shows the β-sheet character of the peptide and 
reveals the important role of the Tyr 8 side chain in the formation of a small hydrophobic core. Figure 




3.3 Conclusions and future directions 
Adapting techniques from conotoxin research and coupling them with modern techniques to 
increase throughput successfully established the synthesis and structural characterization capabilities of 
the Holford laboratory. Difficulties during early manual synthesis attempts of terebrid peptides lead to the 
development of improved protocols. Automated microwave-assisted peptide synthesis allowed for faster 
assembly of peptides, and gave access to SPPS of longer teretoxins. Use of UHPLC for analyzing SPPS 
cleavage products, analytical confirmation of peptide purity, and monitoring oxidative folding reactions 
dramatically reduced the time and cost of peptide synthesis, and oxidative folding. This success is 
demonstrated with the synthesis and structural characterization of Tv1, the first terebrid peptide toxin to 
be structurally characterized9. Demonstrated to be active in a phenotypic assay in polychaete worms, the 
cysteine connectivity of Tv1 is unlike that of similar M-superfamily conotoxins (figure 3.18), suggesting 
that it may have a novel biological target or mode of action. Efforts to identify its biological target using 
electrophysiological recordings, and cell-based assays are ongoing. 
The recombinant expression strategy developed for Tg77, was also proven effective, particularly 
for longer teretoxins. Besides being a viable route for teretoxin synthesis, it also incorporates an 
improvement in throughput by using ligation independent cloning. A recombinant expression system 
analogous to that designed for Tg77, was also used to successfully produce two more toxin peptides from 
Cingulaterebra Anilis Can1, by graduate student Mary E. Wright77, illustrating the general applicability of 
this method to the synthesis of teretoxins. 
Figure 3.18: Structural comparison of Tv1 teretoxin and M-superfamily conotoxins.
Comparison of the NMR structure of Tv1 with that of M superfamily conotoxins SmIIIA, mr3e, and KIIIA 
reveals significant structural differences between Tv1 and these conotoxins despite all having the same 
cysteine scaffold CC-C-C-CC. All structures are shown in cartoon representation with disulfide bonds 
highlighted in yellow. All figures were prepared using PyMol (www.pymol.org). Conotoxin structural 
references are as follows: MrIIIe79d SmIIIA79g and KIIIA79h.
	  
	   51	  
3.4 Materials and methods 
3.4.1 SPPS of terebrid neuropeptides 
All peptide acids were synthesized on Wang-Cl resin. This resin was prepared from commercially 
available Wang resin (Anaspec) using a previously published procedure 80. Racemization free loading of 
the first amino acid was also completed as previously described80. After conjugation of the first  (C-
terminal) Nα-Fmoc-amino acid (Fmoc-AA-OH), resin substitution was calculated using a 
spectrophotometric Fmoc release assay. Briefly, 10-20mg resin aliquots were weighed out, and 
deprotected with 1mL of 20% piperidine in (DMF) for 1 hour. An aliquot of the deprotection solution was 





During Fmoc-SPPS, standard side chain protecting groups were used for all amino acids. Due to 
absence of a priori knowledge of disulfide connectivity, the trityl protecting group was used for all cysteine 
side chains. Chain elongation steps, namely coupling Fmoc-AA-OH, and removal of the Fmoc protecting 
group differed for manual and automated microwave-assisted synthesis. During manual synthesis, 
coupling was effected by adding 3eq. of the Fmoc-AA-OH, 2.99eq. HBTU, and 6eq DIPEA, all dissolved 
in a minimum amount of DMF, and incubating for 1 hour with stirring. Up to 50% dichloromethane was 
added to improve resin swelling properties during difficult coupling reactions. If repeated couplings failed 
to completely react, resin-bound peptides were capped with 10eq Acetic anhydride and 11eq DIPEA in 
DMF to produce Nα-Acetyl capped products in lieu of deletion products which are harder to separate from 
the desired peptide upon cleavage. Deprotection was effected by exposing the peptidyl resin to 5 
volumes of 20% piperidine in DMF for 5 minutes, then 30 minutes. DMF solutions containing 2% 1,8-
Diazabicyclo[5.4.0]undec-7-ene (DBU) and 18% piperidine were used as alternatives for difficult 
deprotection reactions.  
 The ninhydrin test for free amines was used to evaluate the efficiency of coupling and 
deprotection reactions. Briefly, a small aliquot of peptidyl resin (10-30 single resin beads) was withdrawn 
from a peptide synthesis vessel, washed, dried under vacuum, and transferred to a 100mm culture tube. 
One drop each of reagent A (5% w/v ninhydrin in ethanol), B (4:1 phenol:ethanol), and C (2% v/v of 1mM 
aqueous KCN in pyridine) were added to the resin, and the tube was heated to 110°C for 3 minutes. Blue 
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coloration of resin beads indicates the presence of free amines. Couplings reactions were considered 
complete when resin beads remained colorless after this procedure.  
Microwave-assisted, automated peptide synthesis was completed on a Liberty1 instrument (CEM 
corporation). Coupling reactions used 5eq. Fmoc-AA-OH(as 0.5M solution in DMF), 4.99eq. HBTU and 
10eq. of DIPEA (in N-methyl-2-pyrrolidone), and proceeded for 5min, under up to 25W microwave power, 
while maintaining a reaction vessel temperature of no greater than 75°C. Coupling of Fmoc-Cys(trt)-OH 
and Fmoc-His(trt)-OH, was restricted to no greater than 50°C, to prevent racemization and thermal 
cleavage of the trityl group. Fmoc deprotection was effected by 20% piperidine in DMF containing 0.1M 1-
hydroxybenzotriazole (HOBt), for 1 min, then 4 min, at 25W maximum power and 75°C maximum 
temperature.  Residues were preprogrammed to be double-coupled based on information from previous 
manual synthesis attempts, as well as in peptide regions containing several bulky aliphatic amino acids in 
succession. During the synthesis of Arg58, the aspartimide prone sequence Asp-Gly, was introduced as a 
dmb-protected dipeptide, Fmoc-Asp(OtBu)-(Dmb)Gly-OH (Novabiochem), and double coupled.  
Cleavage of peptides from the resin, and removal of all side chain protecting groups was 
accomplished by shaking the peptidyl resin with 5 volume equivalents of reagent K (92.5% trifluoroacetic 
acid (TFA), 2.5% triisopopylsilane (TIS), 2.5% 1,2-ethanedithiol (EDT) and 2.5% water) for 4 hrs. Reagent 
K supernatant containing cleaved products was then filtered from the resin, and peptide components 
were precipitated by addition of 50 volume eq. of cold methyl-tert-butyl-ether.  
Peptide cleavage products were then dissolved in HPLC buffer A (0.1% TFA), and assayed using 
a generic reversed phase UHPLC elution protocol. Briefly peptide cleavage products were loaded onto an 
Acquity UPLC BEH300 C18 column (4.6x50mm, 1.7um particle size, Waters corporation, MA), and 
elution was carried out at 0.6mL/min with 97% HPLC buffer A and 3% HPLC buffer B (80% acetonitrile 
(ACN), 0.1% TFA) for the first 20 seconds, then increasing HPLC buffer B to 75% in a linear gradient over 
2 minutes. This initial screen was used for gradient optimization for each peptide synthesized. Once 
maximal resolution of peptide product from truncated and deletion sequences was attained, the UHPLC 
method was scaled to semi-preparative HPLC, taking into account column dimensions and particle size to 
calculate appropriate flow rates and duration of gradient steps. Semi-preparative purification of 
synthesized Tv1 was completed on an X-Bridge column (10x150mm, 5um particle size, Waters 
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Corporation, MA) by elution at 5mL/min of 20% HPLC buffer B and 80% HPLC buffer A for the first 5 
minutes, then increasing HPLC buffer B to 35% in a linear gradient over 45min.  
The identity of synthesized peptides was confirmed by molecular mass measurement using a MALDI-
TOF (Waters Micromas, MA) instrument, and α-Cyano-4-hydroxycinnamic acid (CHαCN) as matrix. 
3.4.2 Oxidative Folding of Teretoxin peptides 
 Early experiments on several teretoxin peptides tested dimethylsufloxide (DMSO) and ClearOX 
resin as potential oxidizing agents in folding reactions. The yields of these reactions were substantially 
lower than with mixtures of oxidized and reduced glutathione (data not shown). For routine teretoxin 
folding, the starting reaction conditions are 20µM of linear purified peptide incubated in 0.1M Tris-HCl pH 
7.5, 0.1mM EDTA, 10mM GSH and 1mM GSSG. Aliquots of this initial folding reaction are then stopped 
after 15 min, 30 min, 1, 2, 3, 4, and 24 hours by acidification with formic acid (to 8% v/v), and the products 
analyzed by UHPLC using the same column and buffers as described earlier, but with an optimized 
gradient for each peptide. Further folding optimization is accomplished by varying the reaction 
temperature, pH, and including up to 1M NaCl in the folding reaction. For Tv1, optimized folding 
conditions were: 20uM Tv1 incubated in 0.1M Tris pH 10, 1M NaCl, 0.1mM EDTA, 10mM GSH and 1mM 
GSSG for 4 hours. The identity of oxidized teretoxins is confirmed by MALDI-TOF. For Tv1, the optimized 
folding reaction was scaled up, and the product purified on an X-Bridge semi-preparative column (See 
above) by eluting at 5mL/min with 15% buffer B and 85% buffer A for the first 5 min, then increasing 
buffer B to 35% in a linear gradient over 45 min.  
3.4.3 Disulfide mapping of Tv1 
 Purified folded Tv1 was subjected to partial reduction and alkylation procedure by modifying 
previous protocols78, 81. Briefly, 9µL of 1mM Tv1 dissolved in 0.1M citrate pH 3.0 was mixed with 1µL 
20mM TCEP, and incubated in an HPLC microvial for 90min at 4°C. Reduction was stopped by direct 
injection onto an RP-HPLC X-bride column (4.6x150, 5um particle size, Waters Corporation, MA) and 
eluted with 20% buffer B in buffer A for 5 min, then increasing buffer B to 35% in a linear gradient over 75 
min. Six partially reduced species (Figure 3.16) were then collected directly into tubes containing 100uL 
of 200mM NEM in citrate pH 3.0, and incubated for 2h at 37°C. Excess NEM was then removed by 
desalting each of the six fractions using UHPLC. Desalted fractions were then completely reduced by 
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incubation with 100mM TCEP at 55°C for 1hr, and subsequently alkylated by addition of 275µL of 200mM 
IAM, and incubating for 2hrs at 37°C in the dark. The fractions were once again desalted using UHPLC, 
lyophilized, and suspended in 0.5% formic acid for LC-MS/MS analyses. Using a 7 minute gradient, each 
fraction was eluted through a 43mm HPLC-Chip/Q-TOF (Agilent Technologies), to allow complete 
resolution of fully labeled peptides from those with incomplete alkylations. Data, collected in targeted and 
auto MS/MS mode, was processed using molecular feature extraction software and matched to 
theoretical sequences using MassHunter Bioconfirm Qual B.05 software (Agilent Technologies).  
	  






Chapter 4 - Fluorescence Spectroscopy Using Solvatochromic Probes for 
Investigation of Protein Structure, Function and Interactions  
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4.1 Fluorescence spectroscopy in the study of biological systems 
Fluorescence spectroscopy is a powerful tool for studying structure, dynamics and functional 
interactions of biomacromolecules. Unlike high-resolution structural methods, such as X-ray 
crystallography and NMR, which provide a global picture of protein structure, fluorescence spectroscopy 
utilizes a molecular probe to provide information about its surrounding environment. This probe, or 
fluorophore, undergoes electronic excitation upon light absorption, and emits light of a characteristic 
wavelength when it relaxes from its first singlet excited state to the ground state. The interaction of the 
singlet excited state of a fluorescence probe with the local chemical environment can promote proton 
transfer, form charge transfer complexes, cause exciplex formation, result in intersystem crossing to the 
triplet state, promote resonance energy transfer, or cause reorientation of solvent and neighboring group 
dipoles. All of these events influence measurable fluorescence parameters including emission and 
excitation wavelengths, quantum yield, anisotropy, and fluorescence lifetime, thus providing invaluable 
structural and dynamic information about the probe’s environment10. In the context of biological sciences, 
fluorescence measurements can provide a wealth of information on various molecular processes, like the 
interactions of the probe and the surrounding solvent, rotational diffusion of macromolecules such as 
proteins, distances between macromolecular regions, conformational changes, and binding interactions.  
4.2 Protein fluorescence and the intrinsic fluorophore tryptophan 
Using fluorescence spectroscopy to study proteins can be accomplished by utilizing fluorophores 
that are already present in these biological macromolecules. These endogenous probes allow for 
investigation of proteins without chemical perturbation caused by introduction of extrinsic probes. Of the 
twenty encoded proteogenic amino acids, three have aromatic side chains that exhibit fluorescence, and 
are considered intrinsic fluorophores. These are the side chains of phenylalanine (benzene), tyrosine 
(phenol) and tryptophan (indole). Of these three, tryptophan (Trp, W) is most widely employed for the 
study of protein structure, dynamics and interactions. Trp occurs only at about 1 mole% of all proteins, 
more rarely than any other encoded proteogenic amino acid10. This rarity facilitates interpretation of its 
spectral data. Trp also absorbs light at lower energies than other aromatic amino acids, allowing for its 
excitation independent of tyrosine (Tyr, Y) and phenylalanine (Phe, F). The unique photophysical 
properties of Trp, such as sensitivity of its emission to the polarity of the local environment 
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(solvatochromism), propensity for collisional fluorescence quenching, and high anisotropy have 
contributed to its use as a probe in innumerable investigations of protein structure and function. 
Additionally, Trp’s multiexponential intensity decay kinetics have been linked to the local secondary 
structure of the polypeptide chain allowing for gleaning structural information about polypeptides in dilute 
solutions via fluorescence lifetime measurements82. 
In spite of these useful spectral characteristics, Trp is far from being a perfect probe in context of 
protein fluorescence spectroscopy. For example, despite its rare occurrence, most proteins contain more 
than one Trp, inhibiting structural interpretation of fluorescence data due to inability to attribute spectral 
signals to a specific residue. Although fluorescence lifetime decay analysis can be used to distinguish 
between multiple fluorophores in distinct environments, most proteins containing just a single Trp display 
multi-exponential decay kinetics, complicating the application of this approach. A further confounding 
factor is the presence of two nearly isoenergetic excited states resulting from nearly perpendicular 







Figure 4.1: Electronic absorption transition moments of indole10
While 1La is sensitive to the polarity of the environment, 1Lb is not, and emission can occur from either 
state depending on the polarity of the surrounding cavity. However, it was shown that in all but most 
extreme cases Trp emission in proteins occurs from 1La83 . Additionally, both specific (H-Bonding) and 
general solvent effects influence Trp emission, further complicating meaningful structural attribution of 
spectral data. Studies of the interaction of Trp-containing proteins and nucleic acids also present a 
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problem because nucleotides have a strong extinction coefficient in the region of tryptophan absorption 
and thus contribute to a strong inner filter effect, that can be easily misinterpreted as quenching resulting 
from intermolecular interactions10, 84. In summary, while the complexity of indole photophysics has 
prompted detailed inquires into protein fluorescence using Trp as a probe, including studies of Trp 
quantum yield as a function of local environment conducted in our laboratory85, it has also limited 
meaningful structural attribution of spectral data.  
4.3 Tryptophan analogues for structure-conservative spectral enhancement of proteins 
Expanding the spectroscopic utility of Trp in protein fluorescence has been widely pursued. While 
Trp naturally occurs in proteins, some proteins lack a native Trp, or have more than one Trp. Thus, site-
directed mutagenesis can often be used to either introduce Trp at a desired site in a protein, or replace an 
unwanted Trp by a residue with non-interfering spectral characteristics. However, such strategies can 
often alter the structure/function of some proteins, and also do not address the shortcomings of Trp 
photophysics, namely UV excitation, and complexity of solvent effects on its fluorescence.  
One interesting approach of addressing the limitations of Trp as an intrinsic probe came from 
investigations aimed at elucidating the pathway of Trp biosynthesis and its insertion into proteins during 
translation. These studies showed that some nearly isosteric analogues of Trp can be biosynthetically 
inserted into proteins by endogenous cellular machinery, with tryptophanyl tRNA-synthetase found to be 
the key enzyme displaying substrate flexibility86. Consequently, replacement of Trps with non-natural 
tryptophan analogs with enhanced photophysical properties to address the issues of spectral overlap 
while minimizing the effect on structure has been widely pursued19, 87. Since then, a number of Trp 
analogs, each with distinct spectral advantages, were incorporated to create spectrally enhanced 
alloproteins (Figure 4.2). 
These analogs have been incorporated into a protein or peptide in a variety of ways: 
biosynthetically via recombinant expression in a Trp auxotroph in the presence of the analog 87a-c, by in 
vitro transcription/translation using a nonsense suppressor tRNA chemically acylated with the analog19, 88, 
or by direct introduction of the analog during solid phase peptide synthesis 21, 87d. Although the structural 
perturbations introduced by analog incorporation can vary depending on the specific protein and analog, 
the majority of investigations have showed them to be minimal89. 
	  
	   59	  
 
 As summarized by Ross et al.87e, spectral enhancements introduced by analog incorporations 
vary.  While using fluorinated Trps allows for the possibility of studying proteins by 19F-NMR, 4-
fluorotryptophan, 5-hydroxytryptophan (5HTP) and 7-azatryptophan all have desirable properties for 
fluorescence enhancement (Figure 4.2 B,C). 
  4-fluorotryptophan is not fluorescent and is used to silence the signals from unwanted 
tryptophans with minimal structure perturbation. 5HTP and 7-aza Trp exhibit red shifted absorption and 
can be singled out in the presence of Trp using Red-edge excitation. However, significant absorption 
envelope overlap with Trp still exists, barring fluorometric measurements at the absorption maxima of 
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Figure 4.2: Structures and spectral characteristics of Trp and its analogues. A. structures of trypto-
phan (1)  5-fluorotryptophan (2), 4-fluorotryptophan (3), 5-hydroxytryptophan (4), 7-azatryptophan (5), 
their absorption (B), and fluorescence emission (C) spectra. Spectra of non-fluorescent 3 are omitted. 
Spectra reproduced from reference 87e
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emission spectra of 7-aza and 5-OH Trps significantly overlap that of Trp allowing for the possibility of 
misattributing the fluorescence signal (Figure 4.2C). More recently, 4-azatryptophan was shown to be the 
most red-shifted90 of the isosteric tryptophan analogs described above. Having the largest Stokes shift of 
all azatryptophans studied, this analog has a fluorescence emission maximum of 418nm, but still suffers 
from a low quantum yield (0.077 as determined for 4-aza Indole)90. Furthermore, the absorption profile of 
4-aza Trp completely overlaps that of Trp, making it impossible to selectively excite this analog in the 
presence of Trp.  
 Because many Trp analogs are isosteric or nearly isosteric with Trp, they are attractive choices 
for conservative replacement of Trp for fluorescence enhancement. However, these analogs introduce 
only a modest difference in spectral properties, and usually have poor quantum yields, barring sensitive 
measurements.  Hence, there is still a need for probes with a more dramatic shift in fluorescence 
excitation and emission maxima as well as an improved quantum yield.  
4.4 Extrinsic solvatochromic probes to study proteins 
 A variety of extrinsic fluorescence probes, both engineered and natural, can be conjugated to 
proteins to impart even more desirable fluorescent characteristics. Advances in organic synthesis 
provided access to a plethora of such probes11, ranging from the macromolecular green fluorescent 
protein to small molecule organics such as Fluorescin or Dansyl. Among these, small molecule probes 
that display the phenomenon of solvatochromism, and are amenable to site-specific incorporation into 
proteins and peptides are of particular interest14, 91 in the current context. This type of probe can be 
thought of as a way to capitalize on the desirable aspects of Trp fluorescence (sensitivity to the 
microenvironment), while minimizing its shortcomings (UV excitation and complex photophysics). 
Analogous to the discussion of Trp analogues, the ability to incorporate these extrinsic fluorophores site-
specifically into a protein or peptide, as well as the size and charge of these probes are critical for 
minimizing structural perturbation caused by their introduction14. The principles guiding rational design of 
solvatochromic probes with desirable photophysics, as well as the methods of their incorporation into 
proteins and peptides are outlined in subsequent sections. 
4.4.1 The phenomenon of solvatochromism 
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The effects of the environment immediately surrounding a probe on its measurable fluorescence 
characteristics are complex, and can include factors such as solvent polarity, rate of solvent relaxation, 
and rigidity of the local environment among others. However, the effect of solvent polarity alone on 
fluorescence emission of a given probe, partially described by the Lippert-Mataga equation10, can be 
instructive in the general understanding of fluorescence solvatochromism. The simplified Jablonski 
diagram shown in Figure 4.3 shows a fluorophore whose dipole increases in magnitude upon excitation. 
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Solvent relaxation, or reorientation of dipoles of the solvent sphere to accommodate the now larger dipole 
of the probe, occurs on the picosecond timescale, and lowers the energy of the excited state while 
simultaneously destabilizing the ground state.  Return to the ground state by a fluorescence event results 
in emission of photons of lower energy than those absorbed during excitation. Increasing solvent polarity 
causes a greater degree of solvent relaxation, resulting in emission at progressively longer wavelengths. 
Also a consequence of the narrowing of the energy gap caused by relaxation in progressively more polar 
solvents is the increase in the rate of non-radiative decay (Knr)14. As a result, many fluorophores exhibiting 
classic solvatochromism have low fluorescence quantum yields (ϕ) in polar solvents. 
While the Lippert-Mataga equation describes the relationship between fluorescence Stokes shifts 
and general solvent polarity expressed in terms of its dielectric constant and refractive index, it neglects 
specific solvent effects, such as hydrogen bonding. These effects can have a profound influence on the 
photophysics characteristics of a probe, and depend on the structural properties of the fluorophore, which 
in turn determine the mode of interaction of its excited state with the local environment (e.g. H-bonding of 
solvent molecules with H-Bond donors or acceptor moieties on the probe). It is possible to gauge the 
contribution of specific solvent effects on the fluorescence emission of a probe by fitting the spectral data 
to an empirical function of solvent polarity. Several empirical solvent polarity scales were developed, with 
the ET(30) single parameter scale92 and the Catalán 3P multiparamater model93 finding the most use in 
the description of solvatochromic probes. The latter scale is particularly useful, as it allows delineating the 
specific contributions of solvent acidity, basicity and general polarity/polarizability on the emission 
properties of the probe.  
Despite the existence of tools for gauging specific solvent effects, and myriad computational 
studies describing specific excited state processes responsible for environment sensitivity of 
fluorophores, probes that display classic solvatochromism with minimal contributions from specific solvent 
effects are the most sought after. This is because a straightforward relationship between a measurable 
fluorescence parameter and general polarity of the local environment allows description of a region of a 
macromolecule to which the probe is bound with more certainty, even in the absence of knowledge of its 
exact chemical makeup.  
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4.4.2 Photophysical properties of solvatochromic probes 
As shown in Figure 4.3, and described in the Lippert-Mataga equation10(see p. 94), a probe 
exhibiting solvatochromism must undergo a large change in the dipole moment upon excitation. In the 
case of classic solvatochromism, the magnitude of the dipole increases upon excitation. This observation 
allows for the rational design of such probes. The common wisdom for imparting solvatochromism to a 
probe has been to append its aromatic core with flanking electron-donating and electron-withdrawing 
substituents, causing increased charge separation upon excitation. This ubiquitous design feature is the 
one constant among solvatochromic probes developed for monitoring biomolecular structure, interactions 
and dynamics (Figure 4.4).  
Besides the obvious requirement for strong solvatochromism to detect even subtle changes in the 
microenvironment, these fluorophores must satisfy a larger set of photophysical requirements to be useful 
for the study of biomolecules such as proteins and peptides. These include excitation at longer 
wavelengths, a high absorption coefficient and quantum yield. Red-shifted excitation is required to allow 
for selective monitoring of these extrinsic probes in the presence of endogenous fluorophores such as Trp 
and Tyr. Excitation in the visible range of the spectrum is also desirable as it avoids the damaging effects 
of UV light on biological macromolecules, and allows for using such probes for fluorescence microscopy. 
The combination of a high extinction coefficient and quantum yield contribute to the overall brightness of a 
fluorophore thus enabling ever more sensitive fluorescence measurements at lower substrate 
concentrations. Despite significant advances in both organic synthesis and calculation methods that drive 
the rational design of such probes, development of fluorophores that satisfy these requirements while 
minimizing their steric bulk remains a considerable challenge.  
It is important to note that the properties outlined above are just general goals in the development 
of solvatochromic probes, and none of the fluorophores shown in Figure 4.4 can be considered ideal for 
the investigation of all biomacromolecules. Instead, a given probe’s photophysical and steric 
characteristics may make it suitable for one type of experiment and not another. This leads to some 
confusion in describing a particular property of a fluorophore as beneficial or disadvantageous. 
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For example, as mentioned earlier, many of the probes exhibiting solvatochromism have low quantum 
yields in aqueous environments (Figure 4.4). From one perspective this is an advantage, because such 
probes fluoresce brightly upon binding to proteins or membranes while remaining dark in bulk water, 
making them useful as “stains” in fluorescence microscopy. In contrast, their low quantum yields in polar 
environments prevent using these probes to accurately report on particularly polar or water exposed 
protein domains. 
The struggle in balancing desirable photophysics and sterics can be further illustrated by 
following some trends in Figure 4.4. Prodan (N,N-dimethylamino-6-propionyl-2naphthylamine), with its 
remarkable sensitivity to solvent polarity is one of the best examples of classical solvatochromic dyes22, 
and has been widely popular for biological applications despite its UV absorption94. The first attempt to 
red-shift the absorption of this dye resulted in the derivative Anthradan95, which absorbs in the visible, but 
at the cost of a decreased extinction coefficient, reduced solvent sensitivity and added steric bulk. The 
recently synthesized fluorene analogue of prodan, FR096, represents significant improvements in both 
absorption wavelength and solvent sensitivity. However, this dye has not yet been used for biological 
investigations.  
4-N,N-Dimethylaminophthalimide (4DMP)97, is one of the first probes for polarity sensing, and 
thus has found numerous applications in protein fluorescence. While it is prized for its solvent sensitivity 
and small rigid structure, it still suffers from UV absorption and a low extinction coefficient. The extended 
analogue, 6-N,N-dimethylamino-2,3-naphthalamide (6DMN)98, was intended to improve on the properties 
of 4DMP. However, modest improvements in its absorption coefficient and solvent sensitivity are offset by 
lower quantum yields and added steric bulk. In contrast, the more recently developed 
4-N,N-dimethylamino-1,8-naphthalamide (4DMN)99 shows a quite significant improvement in absorption 
wavelength. All dyes in this family are nearly nonfluorescent in water, limiting their applications in 
monitoring interactions when the label has significant water exposure throughout the process.  
 The merocyanine family100 represents the most desirable absorption characteristics, with marked 
red-shifts and very large extinction coefficients. However, their large size and negligible solvent sensitivity 
limits their applications as structural probes.  
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 1-Anilinonaphthalene-8-Sulfonic Acid (1,8-ANS)101, one the first solvatochromic dyes, has found 
numerous applications in protein studies, and still remains relevant, but is virtually nonfluorescent in 
aqueous media. Its structural analogue, the Dansyl fluorophore102 has also found myriad applications in 
protein fluorescence, but despite its improved quantum yield in polar media, it recently declined in 
popularity due to its UV absorption and relatively weak solvatochromism.  
 The coumarin family of dyes103 represents a valuable addition to the tool chest of solvatochromic 
probes. Despite modest solvent sensitivity and UV excitation, coumarin derivatives display higher 
quantum yields with increasing solvent polarity, effectively reversing the trend displayed by many other 
solvatochromic dyes.  
 Nile Red104 is a representative example of the phenoxazine family of dyes, combining red-shifted 
absorption and high brightness. However, its solvent sensitivity is only moderate. A variety of its 
derivatives have recently been developed for the labeling of biomolecules105. Of these, the more compact 
analogues, such as APM106, are of particular interest as they minimize the structural perturbations caused 
their introduction. 
 Dapoxyl®107 shows remarkable solvatochromism together with high quantum yields and 
extinction coefficients. However, its UV absorption has so far limited its biological applications in 
biosensor development. Charged derivatives of this fluorophore, such as PyMPO108, can function as 
alternatives for situations when a hydrophobic label can result in structural perturbation of the 
macromolecule under study.  
Nitrobenzoxadiazole (NBD) is another example of an early solvatochromic probe used for protein 
labeling. Its advantages are its small, rigid structure and red-shifted absorption. While early experiments 
using NBD to track ligand-induced conformational changes in a protein, have provided valuable insights 
for future development of fluorescent biosensors109, its low solvent sensitivity limits its applications to 
cases where the change in environment is particularly drastic.  
 The more recently developed probes, such as 3-methoxychromones (see 3MC-2)110 and 2-
dicyanomethylene-3-cyano-2,5-dyhodrofurans (DCDHF)111, with their red-shifted absorption, high 
brightness, and moderate to good solvatochromism, nicely illustrate the overall goals in the development 
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of fluorescent polarity sensors.  The latter is particularly prized because of its high photostability enabling 
applications in single-molecule fluorescence.  
Among the fluorophores available to date, Fluoroprobe112 is the most sensitive to solvent polarity. 
This bichromic dye exhibits charge transfer through space resulting in its unique sensitivity. However it 
has not found any applications in biology because of its UV absorption, low extinction coefficient and 
strong fluorescence quenching in polar media.  
In summary, many fluorescent polarity sensors are currently in use, and as novel biological 
experiments are becoming more sophisticated, the continued development of probes with improved 
spectral characteristics is increasingly relevant. Importantly this is not a quest for “one fits all” solution, but 
rather an attempt to continually increase the repertoire of tools available for today’s diverse biological 
applications.  
4.4.3 Incorporation of solvatochromic probes into proteins and peptides 
 In addition to meeting a set of photophysical and steric requirements, the introduction of 
solvatochromic probes into proteins and peptides represents another important aspect of their 
development14. In fact, many fluorophores discussed in the previous section and depicted in Figure 4.4 
found great utility in protein fluorescence because they were amenable to site-specific incorporation into 
these macromolecules, while others remain theoretical curiosities because their incorporation methods 
are nonexistent or underdeveloped.  
 There are many techniques for conjugating fluorophores onto proteins and peptides, but in the 
context of polarity-sensing structural probes it is of interest to focus on the methods that enable maximal 
attribution of fluorescence data to relevant structural, dynamic or binding events. Thus, methods that 
introduce the fluorophore into a specific site in any desired region of a peptide or protein are the most 
valuable. Harsh incorporation conditions are less than desirable as they can alter the structure or function 
of the system under study. The common techniques for incorporation of solvatochromic dyes into proteins 
or peptides can be broadly divided into two categories: (1) direct covalent modification and (2) 
introduction of the fluorophore as an unnatural amino acid.  
Direct covalent modification involves preparing a reactive derivative of the fluorophore for 
conjugation with select endogenous functional groups present in polypeptides. The two most common 
	  
	   68	  
approaches involve conjugating probes to amine groups of lysine residues (through the use of amine-
selective acylating functionalities, such as O-succinimidyl esters) or to thiol groups of cysteine residues 
(via thiol-selective electrophiles such as α-halocarbonyls or maleimides). Of the two, cysteine conjugation 
is the preferred method, as this amino acid occurs much more rarely in proteins and its nucleophilic thiol 
functionality is reactive under milder conditions13. Although site-directed mutagenesis allows engineering 
of either cysteine or lysine into virtually any desired site in protein, natural occurrence of these residues 
necessitates mutations at multiple sites prior to labeling, which raises the probability of altering the 
structure and function of the protein. Another drawback of direct covalent modification is low water 
solubility of solvatochromic fluorophores, which often necessitates addition of an organic co-solvent 
during labeling reactions. This can cause denaturation of the protein, requiring the costly and not always 
successful refolding procedure. Finally, because this type of labeling attaches the fluorophore via an 
amino acid side chain, the probe is not held as closely to the protein backbone. This additional 
conformational freedom complicates attribution of spectral data to characteristics of a specific site. 
Engineering solvatochromic fluorophores into amino acid derivatives overcomes many of the 
challenges associated with direct covalent modification. In fact, many of the probes listed in Figure 4.4 
have been made into amino-acid derivatives, which greatly expanded their utility as polypeptide probes. 
Perhaps the most notable example of this is the synthesis of the amino acid Aladan, bearing the Prodan 
side chain, almost simultaneously by two research groups113, which resulted in high-profile publications 
describing the use of this polarity-sensor on protein systems. Introduction of these unnatural amino acids 
can be accomplished at the peptide level during SPPS, at the protein level through suppression of the 
amber stop codon during translation17, or semi synthetically through expressed protein ligation (EPL) 15 16 
of an SPPS assembled peptide bearing the unnatural amino acid with a protein fragment.  
In SPPS, unnatural amino acids bearing solvatochromic side chains could be incorporated 
directly via their corresponding Nα-Fmoc or -Boc derivative.  Protection of reactive side-chains during 
SPPS makes it possible to incorporate virtually any unnatural amino acids, although some of their 
functionalities, such in the case of 4-DMP and 6-DMN114, can cause the formation of undesired side 
products during standard chain elongation procedures.  
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At the protein level, incorporating an unnatural amino acid bearing a solvatochromic side chain is 
possible by chemically acylating it onto a modified tRNA which inserts it into the protein in response to an 
unused stop codon (TAG) during recombinant protein expression17. This technique is extremely difficult to 
implement, often suffers low incorporation yields, results in truncated recombinant proteins, and is not 
necessarily compatible with any unnatural amino acids13-14. 
 The ability to incorporate solvatochromic probes during SPPS can also be extended to the protein 
level through protein semi synthesis by EPL. Assembled by SPPS, peptides bearing the probe can be 
ligated to the C- or N-terminus of a recombinantly synthesized protein fragment. EPL relies on a 
chemoselective transthioesterification of a thioester and an N-terminal cysteine residue, which upon an S 
to N intramolecular acyl shift results in a native peptide bond.  N-terminal ligation occurs between a 
fluorophore-bearing peptide thioester prepared by SPPS and a recombinant protein fragment whose N-
terminal cysteine residue is exposed by proteolytic cleavage. Alternatively, the probe-bearing peptide with 
an N-terminal cysteine prepared by SPPS is ligated with a recombinant protein fragment which is 
modified into a C-terminal thioester by using a defective intein-based approach115. Although EPL is a 
powerful technique to extend the chemical flexibility of SPPS to protein systems, probe attachment using 
this strategy is limited to within approximately 40 residues from the C- or N- termini because of 
decreasing SPPS efficiency with increasing peptide length.  
4.5 Converting a tryptophan analogue to a sensitive extrinsic probe: oxidative coupling reaction of 5-
hydroxytryptophan (5HTP) with amines 
The unique reactivity of one Trp analogue, 5HTP, suggests a possibility of creating a probe with 
both desirable photophysics and a built-in incorporation method. 5HI, the side chain moiety of 5HTP, is 
known to react with primary amines under mild, biologically compatible conditions to produce a 
fluorescent adduct 6H-oxazolo[4,5-e]indole (Figure 4.5). As this adduct extends the conjugation along the 
solvent sensitive 1La transition of indole, it also has the potential to exhibit solvatochromism. Furthermore, 
since straightforward methods for incorporating 5HTP into peptides via standard Fmoc-SPPS without 
requiring side chain protection21, and into proteins through selective pressure incorporation20 exist, this 
chemistry can be used to create a fluorophore capable of site-specifically labeling these macromolecules.  
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 This oxidative coupling reaction, first discovered during the investigation of an antitumor drug 
ellipticine116, has been employed in quantifying 5-hydroxyindoles by fluorescence detection18, and has 
been recently used in preparing fluorescent cyclic peptides19.  Using benzylamine as the primary amine 
nucleophile in a reaction with 5-hydroxyindole, produces 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI), a 
fluorophore with significantly red-shifted excitation and emission (Ex. 345nm, Em. 465nm), a dramatically 
improved quantum yield (0.54 compared to 0.17 for Trp) and a high extinction coefficient (1.54x104 vs. 
6.57x103cm-1M-1)19. Although its solvatochromism is yet to be determined, these initial findings suggest 
that PHOXI can be a valuable addition to the tool chest of existing solvent sensitive probes, having 
absorption and emission characteristics that are distinct from intrinsic protein fluorophores, and a built-in 
method of its incorporation into proteins and peptides.  
 
4.6 Project Research Objectives 
 The overall goal of this project is to develop the PHOXI fluorophore as a solvent-sensitive probe 
for the study of protein and peptide systems, by evaluating both its photophysics and site-specific 
incorporation capability. First, to investigate the solvatochromism of PHOXI, the core fluorophore is 
synthesized and its absorption, steady-state as well as time-resolved fluorescence properties are studied 
in a series of solvents spanning the dielectric continuum. The extent and nature of its solvent sensitivity is 
evaluated by the application of the Lippert-Mataga equation and the Catalán 3P empirical solvent model. 
Density functional theory calculations are be employed to investigate the structure of PHOXI and the 
nature of its photophysical behavior.  
 Site-specific incorporation of this fluorophore by derivatization of peptides containing 5HTP is also 
evaluated. The first and only use of this reaction on a polypeptide system was reported in 200919, where it 
Figure 4.5: Oxidative Coupling of 5-hydroxindole with primary amines
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was used to modify 5HTP containing peptides. Although this report sets an important precedent of the 
viability of this reaction to introduce the PHOXI fluorophore into biomolecules, it lacks the necessary 
evidence of selectivity and biocompatibility of this derivatization because the 5-HTP peptides were 
prepared using in vitro translation in minute (sub µM concentration in ~10µL) quantities, only allowing for 
determination of reaction products by mass spectrometry without chromatographic separation. Thus, the 
authors’ claim, based on mass spectrometric evidence, that only the desired products are formed during 
this derivatization, is premature. It is also inconsistent with the proposed mechanism for this reaction117, 
which suggests that unwanted products can arise from attack of the p-quinoneiminemethide intermediate 
by nucleophiles other than the intended benzylamine (Figure 5.1).  
The current work focuses on using model peptides to evaluate the PHOXI derivatization strategy 
by monitoring reaction products using HPLC, allowing for optimization of reaction conditions. 
Recombinant synthesis of 5HTP containing model proteins by modified selective-pressure incorporation 
methods is also attempted to demonstrate the viability of the PHOXI incorporation strategy at the protein 
level.   
	  








Chapter 5 - Evaluation of 5HTP Derivatization in Peptide Systems and Structural 
and Solvatochromic Description of PHOXI  
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5.1 Background: Oxidative coupling of 5-hydroxyindole with primary amines 
 As discussed in section 4.3, tryptophan analogues have been widely pursued for the spectral 
enhancement of proteins. These structure-conservative probes are easily introduced into proteins in 
response to native Trp codons by selective pressure incorporation, resulting in site-specific labeling 
without the use of difficult and time-consuming strategies used for introduction of extrinsic solvatochromic 
probes (EPL semi synthesis, and nonsense codon suppression).  However, the spectral enhancement 
afforded by these analogues is modest, and is easily eclipsed by that of rationally designed 
solvatochromic fluorophores. One of the Trp analogues, 5HTP, owing to its reactivity with primary amines 
under mild conditions to produce a new fluorophore with improved properties, offers an opportunity to 
capitalize on hassle-free selective pressure incorporation, while achieving desirable photophysics 
comparable to extrinsic polarity sensing probes. 
 
 5-hydroxyindole (5HI), the side chain of 5HTP, has long been known to undergo oxidation under 
mild conditions118. A study investigating the oxidation products of 5-hydroxytryptamine (the 
neurotransmitter serotonin, which bears a 5HI functionality) under biomimetic conditions using H2O2-











































Figure 5.1: Oxidation products of 5HI under biomimetic conditions
HO
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products suggests that the reaction proceeds through a highly reactive intermediate that is susceptible to 
capture by nucleophiles at the 4 position.  
5HI oxidation in the presence of external nucleophiles was first encountered during investigations 
of 9-hydroxy derivatives of the plant alkaloid ellipticine, which contains a 5HI moiety within its structure. 
5HI was found to be oxidized to the p-quinoneiminemethide, a potent electrophilic species119(Figure 
5.2A). This intermediate was found to undergo regiospecific Michael type additions by a variety of 
oxygen, sulfur and nitrogen nucleophiles, which were found to add specifically to the C4 indolic position) 
(Figure 5.2B)116. Further investigations used the amino group of aliphatic amino acids as the nucleophile 
to trap the p-quinoneiminemethide intermediate (Figure 5.2C)120, however, the structural assignment of 
these amino acid adducts was later called into question, and was revised to the annulated oxazolo 
derivatives, the fluorescent properties of which are exploited in later analytical studies (figure 5.2D)121.  
 
 The generality of this reaction with various primary amine nucleophiles was then explored on a 
model system 6-hydroxyindole-2-carboxylate, and a mechanism for oxazole formation was proposed 
(Figure 5.3 shows the mechanism as it applies to 5HI)117. While benzylamine gave the highest yield of 
oxazole (61%), it is interesting to note that reaction with ethanolamine produced the unsubstituted 












































Figure 5.2: Reactions of 9-hydroxyellipticium with nucleophiles under oxidative conditions
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In the early 1990’s analytical chemistry researchers reported on the determination of 5-HIs 
(namely the neurotransmitter serotonin (5-OH tryptamine) and related metabolites) by spectrofluorometric 
detection of novel oxazole containing fluorophores formed during oxidation of 5HIs in the presence of 
benzylamine or 3,4-dimethoxybenzylamine18a. The fluorophore produced upon benzylamine 
derivatization, 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI) (Figure 5.4), was reported to have fluorescence 
emission maximum at 481nm with excitation at 350nm. These spectral characteristics are a significant 
improvement over Trp analogues, suggesting that this derivatization reaction can be of use for spectrally 
enhancing peptides and proteins. The reaction proved to be substrate specific, as no fluorescence was 
observed in a reaction with unhydroxylated tryptophan and biological phenols, and was conducted in 
aqueous buffer with dimethylsulfoxide (DMSO) as the oxidizing agent. It was also shown that 
substitutions on the aryl ring of the amine reagent did not affect fluorescence properties of the resulting 
oxazoles to a great extent, with the 3,4-dimethoxybenzyl derivative having λem=474nm. Later analytical 
studies applied this method to increasingly complex biological systems further attesting to the 
chemoselectivity of this reaction18b, 122. These later investigations used the mild oxidizing agent potassium 
hexacyanoferrate (K3[Fe(CN)6]), which is too weak to oxidize any endogenous functional groups present 







































expected to result in protein denaturation.  The focus of these studies, however, was to develop a robust 
analytical method for detection of 5HI-containing neurotransmitters and related metabolites, not to apply 
this chemistry for spectral enhancement of macromolecules. Thus, the authors were concerned with 
optimizing reaction conditions to attain maximal fluorescence emission, without regard to yield or any 
nonfluorescent byproducts that may have formed.  
The first and only use of this reaction on a polypeptide system was reported in 200919, where it 
was used to modify 5-hydroxytryptophan containing peptides. The authors used benzylamine and 
4-biotynyl-benzylamine in an intermolecular reaction with 5-HTP containing peptides to successfully
synthesize (PHOXI) modified peptides. Encouraged by the results of these intermolecular reactions, the 
authors then included both the benzylamine moiety and the 5-HTP residue onto the same peptide and 
were able to produce a cyclized peptide upon oxidation with K3[Fe(CN)6]. These investigators also varied 
the residues adjacent to 5HTP in the peptide sequence to investigate the proclivity of canonical amino 
acids to introduce undesired side products during derivatization. Of all proteogenic amino acids, only 
cysteine was found to give an undesired side product, presumed to be resultant from the attack of 
cysteinyl sulfhydryl group on the reactive intermediate formed during oxidation of 5HTP. The investigators 

























Figure 5.4: Fluorogenic oxidative coupling of 5HI (1) and benzylamine. Initial oxidation forms p-qui-
noneiminemethide (2) which is highly reactive to nucleophiles at position 4. Nucleophilic attack by benzyl-
amine at this position, followed by oxidation to the imine, a 1,5 hydride shift, and ring closing yields (3) 
2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI).
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(λmax=326nm, ε=1.54 x 104 cm-1M-1) of PHOXI for the first time. However, because all of the peptides in 
this study were produced by in-vitro ribosomal synthesis, which is done on a very small scale	   (sub µM 
concentration in ~10µL), no chromatographic separation was performed on reaction mixtures. Instead the 
authors rely solely on MALDI-TOF mass spectrometry and fluorescence measurements to corroborate 
successful derivatization results. Using these techniques, it is impossible to determine the efficiency of 
the derivatization, or ascertain the absence of undesirable side products, the existence of which is likely 
according to earlier studies highlighting the reactivity of the p-quinoneiminemethide intermediate. A recent 
investigation of products, yields and kinetics of reactions of 5HI and other proquinoidal analytes 
(catechols) with benzylamine and related nucleophiles further calls into question the absence of side 
products reported by Yamagishi et al.19, with only 30% yield of PHOXI reported when 5HI is reacted with 
benzylamine under idealized conditions123. 
While the goal set by Yamagishi et al.19 was to develop a novel way of producing cyclic peptides, 
the few spectral properties of PHOXI reported in the study, namely high brightness (through a 
combination of extinction coefficient and quantum yield), and visible range fluorescence emission, serve 
as an important precedent for employing this strategy for spectral enhancement of peptides and proteins. 
The fact that 5HTP can be readily introduced into proteins by selective pressure incorporation17, 87a and 
into peptides during standard Fmoc SPPS21, combined with evidence of chemoselectivity and 
biocompatibility of its derivatization to produce PHOXI provided by both the aforementioned analytical 
chemistry studies18, 122, and Yamagishi et al.19, suggests that this chemistry can be viable for spectral 
enhancement of these biomacromolecules.  
This project focuses on investigating the photophysics of PHOXI, and describes its 
solvatochromism, which was found to be comparable to established polarity sensing probes, for the first 
time. The viability of PHOXI derivatization is also investigated using model 5HTP containing peptides, and 
ways to minimize formation of undesired byproducts are identified, by chromatographic separation and 
monitoring of derivatization reactions. Recombinant production of 5HTP-containing proteins with the goal 
of demonstrating PHOXI derivatization at the protein level is also attempted.  
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5.2 Results and Discussion 
Two 5HTP containing peptides, tryptophanyl-5-hydroxytryptophan, and TrpZip2 (SWT-5HTP-
ENGKWTWK) were used to evaluate PHOXI derivatization conditions. Monitoring reaction products by 
HPLC allowed for identification of factors that minimize undesired product formation during the PHOXI 
derivatization procedure.  Fluorescence and MS analysis confirmed the spectral enhancement and the 
identity of PHOXI derivatized peptides. The β-hairpin structured peptide TrpZip2 was also used to 
ascertain the extent of structural perturbation caused by introduction of PHOXI using circular dichroism 
(CD) spectroscopy.
PHOXI was successfully synthesized from 5HI and benzylamine by adapting a previously 
published procedure117, and its spectroscopic properties (fluorescence emission, excitation, quantum 
yields and lifetimes) were investigated in six neat solvents spanning the dielectric continuum. PHOXI’s 
fluorescence emission maximum was found to be strongly dependent on the polarity of the surrounding 
media. Its solvatochromism was further investigated by analysis of spectral data using the Lippert-Mataga 
equation, and Catalán 3P empirical solvent scales. PHOXI’s structure and origins of its solvatochromism 
were further investigated by density functional theory (DFT) calculations.  
Attempts to create more structurally conservative analogs of PHOXI, guided by the fact that 6-
hydroxyindole-2-carboxylate has been shown to react with amines of the general structure R-CH2-NH2 to 
produce oxazoles of the general structure of PHOXI, with R replacing the phenyl ring117. Specifically, 
analogs of PHOXI where the phenyl ring is replaced with H were investigated to minimize the size of this 
fluorophore and thus the structural perturbation caused by its introduction into peptides and proteins.  
There are precedents for using methylamine124 or ethanolamine117 as nucleophiles, albeit in organic 
media, to produce these unsubstituted PHOXI analogs. In contrast to benzylamine, attempts to use these 
reagents to label peptides in a biologically compatible manner were not met with success (data not 
shown). While methylamine derivatization did not produce any fluorescent products contrary to a patent 
claim124 the reaction with ethanolamine produced 3 fluorescent products, two of which were difficult to 
separate by RP-HPLC. The formation of these three fluorescent adducts is consistent with previous 
reports121, but due to the difficulty in resolving them, derivatization with ethanolamine was not pursued 
further. 
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Biosynthetic incorporation of 5HTP into glutathione-S-transferase (GST) and horse skeletal 
muscle myoglobin (HMb) with the intent of demonstrating PHOXI derivatization at the protein level was 
also attempted. 5HTP incorporation into GST was achieved at a very low level (data not shown), and 
although subsequent PHOXI derivatization did produce a characteristic PHOXI fluorescence signature, 
the sample was not homogeneous due to the presence of 4 Trps in GST and low 5HTP incorporation 
efficiency. Attempts at expression of the simpler 2 Trp containing HMb using two different expression 
systems were not met with success. In view of the fact that others have successfully accomplished 5HTP 
incorporation into proteins87a-c, these efforts were not pursued further, with the primary focus on 
demonstrating the viability of PHOXI derivatization on peptidic systems, and thorough description of its 
photophysical properties.  
5.2.1 Biosynthetic Incorporation of 5HTP into proteins 
Initial attempts to incorporate 5HTP were done using glutathione-S-transferase (GST) as model 
protein substrate. Although this 4 Trp-containing homodimeric protein is a less than ideal system to test 
the PHOXI derivatization strategy, it was chosen because it remains soluble and expresses to high levels 
in E. coli. Furthermore, a plasmid vector (pET41b+) encoding GST is commercially available eliminating 
the need for cloning. Although traditional approaches to Trp analogue incorporation rely on using Trp 
auxotrophic hosts, these bacterial strains are not commercially available. Instead, an alternative 
approach125, which uses an inhibitor of aromatic amino acid biosynthesis N-phosphomethylglycine 
(glyphosate) was used. Briefly, bacterial hosts are first grown to log phase in rich media, and then 
transferred to minimal media (devoid of Trp) containing glyphosate, 5HTP, as well as supplements of Tyr 
and Phe, prior to induction of protein expression. 6x His tagged GST produced under 5HTP incorporation 
conditions was then purified by Ni-NTA, and incorporation of 5HTP was checked by subjecting it to 
digestion with trypsin, and MS analysis of resulting peptides against theoretical values. This analysis 
proved inconclusive, as observed m/z values corresponding to 5HTP containing peptides were nearly 
identical to other predicted tryptic fragments that do not contain Trp. Subjecting these peptides to MS/MS 
analysis was also inconclusive, as most fragment ions observed did not contain Trp. Nevertheless, 
recombinantly produced GST was subjected to PHOXI derivatization conditions. Subsequent 
fluorescence analysis did show characteristic PHOXI fluorescence, but the spectrum was complex and 
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the signal was very weak, suggesting very low 5HTP incorporation levels and protein sample 
heterogeneity (Data not shown). Because GST contains 4 Trps with varying degrees of solvent exposure 
this result is hardly surprising.  
 Horse skeletal muscle myoglobin (HMb), containing one surface-exposed and one buried Trp, was then 
chosen as a simpler protein model system. It was envisioned that that once 5HTP is incorporated into 
both sites, PHOXI derivatization would occur only at the surface exposed site allowing for spectroscopic 
differentiation of the two Trps. The coding sequence for HMb was successfully subcloned into the same 
pET41b+ vector, replacing the coding sequence for GST. While expression of HMb under non-
incorporation conditions produced high levels of both soluble and insoluble protein (which had to be 
refolded and reconstituted with hemin) with a characteristic red color, no expression was observed under 
incorporation conditions. Low expression levels (or no expression) under analog incorporation conditions 
were also reported by a number of groups utilizing the pET expression system and are summarized by 
Ross et al20. These issues are attributed to the fact that this system requires the synthesis of T7 RNA 
polymerase upon induction of expression, which in turn transcribes the protein of interest. Because 
expression is induced under incorporation conditions, T7 RNA polymerase, which contains 17 Trps, can 
be rendered non-functional, resulting in no expression and no incorporation. To mitigate this problem, the 
use of the pQE expression system, which does not require the synthesis of new proteins upon induction 
of expression was attempted. The coding gene for HMb was again subcloned into the pQE60 vector. New 
E. coli host strains M15 and SG13009 were made competent and successfully transformed with
pQE60HMb. However, no protein expression was observed even under non-incorporation conditions. 
Due to these persistent problems, 5HTP incorporation into proteins was no longer pursued. 
5.2.2 Evaluation of PHOXI derivatization of model peptides 
WWOH readily reacted with benzylamine in borate buffer, pH 8.0, in the presence of 2mM 
K3[Fe(CN)6] to produce fluorescent PHOXI adduct within 10 minutes at room temperature. After 
separation of reaction products by HPLC, a major peak with high absorption at 326nm, characteristic of 
PHOXI was isolated. This peak was isolated, and its identity confirmed by mass spectrometry as NH2-
Trp-PHOXI-OH (Figure 5.5). Fluorescence spectrum of this product was consistent with free PHOXI 
emission and excitation, further corroborating its identity as a PHOXI peptide adduct. 
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HPLC monitoring of reaction products observed during the PHOXI derivatization of WWOH under 
varying conditions is shown in Figure 5.6A, and the fluorescence spectrum of NH2-Trp-PHOXI-OH 
showing characteristic PHOXI visible emission with λmax=451nm and a marked increase in intensity 
Figure 5.5: Mass spectra of Tryptophanyl-5-hydroxytryptophan before and after PHOXI derivatiza-
tion.   (A) NH2-Trp-5HTP-OH Calculated [M+H] 407.17; observed [M+H] 407.18 (B) NH2-Trp-PHOXI-OH 
N Calculated [M+H] 508.19; observed [M+H] 508.15
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relative to NH2-Trp-5HTP-OH is shown in figure 5.6B. The PHOXI emission increase is due to synergistic 
effects of a high extinction coefficient (4.5 × 103 M-1cm-1 as measured in 0.5M Borate pH 8.0) and 
quantum yield (0.54) of PHOXI. 
 Conducting the oxidation reaction in the absence of benzylamine (Figure 5.6A, lower left) 
produces a number of products. This is consistent with the highly reactive nature of p-
quinoneiminemethide intermediate 2 (Figure 5.4) that is formed upon oxidation of 5HTP, and with 
previous studies of oxidation of 5-hydroxyindole118a showing a complex mixture of oligomeric products 
resulting from nucleophilic capture of intermediate 2 at the 4 position.  However, in the presence of large 
excess of benzylamine, the fluorescent PHOXI adduct is the major product of the reaction (Figure 5.6A, 
upper right).  
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Figure 5.6: A. HPLC monitoring (A), and fluorescence enhancement of NH2-Trp-5HTP-OH (B), upon 
derivatization with PHOXI. All reactions are carried out in 250mM Borate buffer pH 8.0 for 10min, with 
the following additions: ■ – 10μM(+) or 100μM(++) NH2-Trp-5HTP-OH, ▲ – 2mM K3[Fe(CN)6],● – 0.5M 













Figure 5.7: HPLC Monitoring of TrpZip2(5HTP) before (A) and after (B) PHOXI derivatization.Reac-
tion carried out in 250mM Borate buffer pH 8.0, with 10μM TrpZip2, 2mM K3[Fe(CN)6], and 0.5M benzyl-
amine for 10min. Asterisk indicates desired PHOXI adduct.
Figure 5.8: MALDI-TOF spectra of TrpZip2(5HTP) before and after PHOXI derivatization. (A) 
SWT-5HTP-ENGKWTWK Calculated [M+H] 1624.75; observed [M+H] 1624.83 (B) SWT-PHOXI-ENGK-
WTWK  Calculated [M+H] 1726.72; observed [M+H] 1726.92.
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Derivatization of TrpZip2 also afforded the desired PHOXI labeled adduct, albeit with formation of 
a greater number of byproducts (Figure 5.7). Despite the presence of a number of nonfluorescent 
oxidation products, the PHOXI adduct was readily separable by HPLC, and its identity was confirmed by 
MALDI-TOF MS (Figure 5.8). 
The concentration of 5HTP-bearing peptide had a profound effect on the number and amount of 
undesired byproducts produced during derivatization.  Undesired byproducts are produced when the 
peptide concentration is increased from 10 to 100µM (figure 5.6A, lower right). These products appear at 
the same retention time as those formed during the oxidation of WWOH in the absence of benzylamine. 
This finding suggests that at higher concentrations unwanted products result from capture of intermediate 
2 by another molecule of peptide.  It was found that generally keeping the 5HTP-bearing peptide at 
concentration of 20µM or below eliminates the majority of these byproducts.  Some unwanted products, 
however, are insensitive to peptide concentration (note minor peaks in Figure 5.6A, upper right). 
Presumably, these arise from intramolecular capture of intermediate 2 by reactive groups on the peptide 
itself. The fact that the amount of these substrate concentration-independent products varies with the 
sequence of the 5HTP peptide gives further credence to this assumption, as peptides with differing 
sequence can have varying amounts of nucleophilic groups in proximity to the 5HTP reaction center. 
Although it was impossible to eliminate these byproducts by altering reaction conditions, the desired 
PHOXI derivatized product was easily identifiable and separable by HPLC for both WWOH and a TrpZip2.  
To ensure that PHOXI derivatization conditions are selective for 5HTP only, a control reaction 
was also conducted using the peptide Aβ-40, which does not contain 5HTP but has all canonical 
amino acids except for cysteine, tryptophan and proline (Figure 5.9). This peptide was found to not be 
affected by reaction conditions used for PHOXI derivatization. 
Derivatization of these two 5HTP-containing model peptides shows that the PHOXI fluorophore 
can be introduced by a quick and selective oxidation reaction in aqueous buffer in the presence of 
benzylamine. While unintended reaction byproducts can be observed during derivatization of 5HTP 
bearing peptides, the Aβ-40 peptide, which is devoid of 5HTP, is completely unaffected by the reaction 
conditions, attesting to the selectivity of this reaction. Because the byproducts present during the 
oxidation of 5HTP peptides in presence of benzylamine are the same as those formed during oxidation of 
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5HTP peptides in its absence, it is reasonable to conclude that these species are formed by capture of 





































Figure 5.9: HPLC monitoring of PHOXI derivatization of Aβ-40 (DAEFRHDSGYEVHHQKLVFFAED-
VGSNKGAIIGLMVGGVV). All reactions are carried out in 250mM Borate buffer pH 8.0 for 10min, with the 
following additions: ■ – 20μM Aβ-40, ▲ – 2mM K3[Fe(CN)6],  ● – 0.5M benzylamine. (A) Derivatization 
Reagents only (B) Aβ-40 peptide only; (C) Derivatization Reagents and Aβ-40 peptide; (D) Chromatogram 
C with A subtracted.
Although the presence of these side products is less than desirable in the context of peptide 
labeling, their formation is consistent with the proposed reaction mechanism117 and is additionally 
documented in previous reports118a, 123. However, even with this inherent limitation, PHOXI derivatized 
products are easily visualized and isolated by RP-HPLC for both peptides tested. Overall, the oxidative 
coupling reaction of 5HTP peptides to produce PHOXI offers a fast and easy protocol for labeling of 
peptides: the reaction is assembled from just three components in aqueous buffer, and is completed in 10 
minutes or less. Furthermore, because PHOXI is assembled in-situ using water-miscible benzylamine, it 
avoids the need for inclusion of harsh organic solvents during labeling reactions, an otherwise necessary 
step during labeling with many common organic fluorophores, which suffer from low water solubility. 
Taken together, these above findings suggest that PHOXI labeled peptides are easily accessed 
through oxidation of 5HTP peptides in the presence of benzylamine and subsequent RP-HPLC 
purification. The PHOXI fluorophore is introduced site-specifically at the 5HTP site, and because it only 
modifies the indole side chain of 5HTP, the PHOXI label is introduced in a conformationally restricted 
manner, being linked to the peptide backbone through a single methylene bridge. For a probe to be useful 
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in characterization of the microenvironment, this short and rigid tether offers clear advantages over other 
common fluorophore attachment strategies (such as through side chain and terminal amine groups, as 
well as cysteine thiol groups), which result in longer flexible tethers and greater degrees of freedom.  
The PHOXI labeling strategy is applicable to wide variety of biomolecules, primarily due to the 
ease of introduction of 5HTP into peptides and proteins. For example, 5HTP is easily incorporated as its 
Fmoc derivative during SPPS using standard protocols21, incorporated into proteins in response to a Trp 
codon during recombinant expression in a Trp auxotrophic host20, or introduced into a desired site by 
means of nonsense suppression19. Furthermore, recent work utilizing PHOXI as a fluorescent linker for 
peptide immobilization suggests that Fmoc protected tryptophanyl PHOXI derivative can be introduced 
during SPPS as well126.  
Applying this chemistry to 5HTP protein substrates is expected to present challenges associated 
with separation of the correctly PHOXI labeled protein from undesired byproducts. While RP-HPLC 
purification may prove sufficient for some protein substrates, inadequate resolution and unwanted protein 
denaturation in HPLC buffers are among the expected challenges. However, a workaround solution 
based on substrate flexibility of this fluorogenic coupling reaction can be envisioned. Several groups 
reported that benzylamines substituted at one or more of the phenyl positions still react with 5HTP to form 
fluorescent adducts analogous to PHOXI18a, 19. One of these reaction variants included the introduction of 
biotynyl benzylamine upon oxidation of a 5HTP peptide substrate19. Because unwanted byproducts arise 
from the capture of the reactive intermediates by nucleophiles other than the intended benzylamine, using 
benzylamines functionalized with non-nucleophilic affinity tags, can facilitate the separation of correctly 
labeled protein products through affinity purification. 
5.2.3 Photophysical and solvatochromic properties of PHOXI 
Spectroscopic properties of PHOXI derivatized peptides 
Figure 5.10 shows the fluorescence emission and excitation spectra of WWOH (A) and TrpZip2 (B) 
before and after PHOX derivatization. The excitation maxima of PHOXI analogues of WWOH and TrpZip2, 
were found to be 336nm and 341nm respectively. These wavelengths are outside of the Trp absorption 
envelope allowing for selective excitation of PHOXI in presence of Trp.  PHOXI and Trp also form a FRET 
pair. We have computed the critical Förster distance, R0= 23.5Å for the PHOXI-Trp system. This value 
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falls into the useful range for distance measurements in the context of biological macromolecules.  
Evidence of FRET can be seen in the emission spectra of PHOXI bearing peptides upon excitation at 
280nm (Figure 5.10, dashed lines). 
 
The structural perturbation caused by PHOXI substitution was also probed by obtaining CD 
spectra of TrpZip2 bearing either 5HTP or PHOXI at position 4 (Figure 5.11). TrpZip2 is engineered to 
adopt a β-hairpin structure, stabilized by stacking interaction of two pairs of tryptophan residues127. 
Although one of these structure-inducing Trps is replaced by the bulkier PHOXI, the PHOXI derivative of 
TrpZip2 still retains some of its β-hairpin structure. As shown in Figure 5.11, the positive elipticity at 
230nm of PHOX-bearing TrpZip2 at 25°C is approximately the same as that of 5HTP-bearing TrpZip2 at 
80°C. 


























Figure 5.10: Normalized fluorescence excitation and emission of  NH2-Trp-5HTP-OH vs. 
NH2-Trp-PHOXI-OH (A) and TrpZip2(5HTP) vs. TrpZip2(PHOXI) (B). Emission spectra for PHOXI 
peptides are shown either with excitation at 336nm (solid black), or 280nm (dashed black). 
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Solvatochromism 
 To glean the utility of PHOXI as a spectroscopic probe capable of providing structural information, 
it was synthesized from 5HI and benzylamine, and its spectroscopic properties in six different neat 
solvents spanning a range of polarity were investigated. The results are summarized in Table 5.1, and 































Figure 5.11: Effect of PHOXI derivatization on β-hairpin stability of TrpZip2 probed by CD. A. 3D 
structure of TrpZip2 stabilized by Trp interactions (RCSB PDB entry 1LE1 rendered using UCSF Chime-
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Table 5.1: Spectroscopic properties of PHOXI in neat solvents 
Solvent λabs(nm) λex (nm) λem (nm) γStokes(cm-1) φF (±10%) Lifetime (ns) 
Cyclohexane 331 331 372 3330 0.6 1.69 
Toluene 322 336 390 5415 0.69 1.91 
1,4-Dioxane 333 335 409 5580 0.78 2.51 
Acetonitrile 320 332 427 7831 0.72 3.29 
Methanol 325 336 437 7886 0.55 4.06 
Water 321 336 459 9366 0.54 5.71 
 
PHOXI fluorescence emission maxima were found to be very sensitive to solvent, exhibiting red-
shifted emission with increasing solvent polarity. PHOXI emission redshifts by 87nm in water relative to 






































































Figure 5.12: Spectroscopic properties of PHOXI in solvents of varying polarity. (A) absorption, 
offset; (B) normalized fluorescence emission ; (C) Multi-parameter fits of  PHOXI and Prodan (constructed 
using previously published Prodan emission data128) fluorescence maxima to a global solvent parameter, 
SP, as defined in the Catalán 3P model93 
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Vibrational structure is present in the emission spectra of PHOXI in non-polar solvents cyclohexane and 
toluene, but not in more polar solvents (Figure 5.12). While PHOXI absorption maxima did not vary 
significantly (spanning a range of only 10nm), the quantum yields were found to vary, but remained high 
(between 0.54 and 0.78) in all solvents studied. Fluorescence lifetimes exhibited single exponential decay 
(Figure 5.13) and varied between 1.69ns (cyclohexane) and 5.71ns (water), increasing with solvent 
polarity. Succeptibitily of PHOXI to photodegradation was also tested by exposure to UV light and 
monitoring the decrease of its fluorescence intensity at the maximum over time. The experimental set up 
was identical to that used to probe photostability of Prodan and its analogue FR096. After 1 hour, a 
solution of PHOXI in toluene had 72% of its fluorescence intesity remaining, compared to 10% for 
Prodan96 and 76% for FR096. 
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Figure 5.13: Fluorescence lifetime decay curves for PHOXI in six neat solvents. Decay (red) and 
instrument response (blue) curves are plotted on a log scale. The fitted functions and residuals sre shown 
in green. All fits were done using single exponentials, except cyclohexane and 1,4-dioxane, which were 
fitted using 3 exponentials, and only the lifetime of highest amplitude is shown. The low amplitude 
lifetimes in these cases are considered artifacts introduced by the broad instrument response function.
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Table 5.2 Solvent parameters used for analysis of PHOXI solvatochromism 
Solvent SPP SB SA ε Δf 
Cyclohexane 0.557 0.073 0 2.02 -0.0017 
Toluene 0.655 0.128 0 2.38 0.0132 
1,4Dioxane 0.701 0.444 0 2.25 0.0245 
Acetonitrile 0.895 0.286 0 37.5 0.3054 
Methanol 0.857 0.545 0.605 32.7 0.3074 
Water 0.962 0.025 1.062 80.1 0.3200 
SPP, SB and SA are Catalán’s empirical solvent parameters of polarity/polarizability93a, basicity93b and 
acidity93b respectively, ε is the dielectric constant, Δf is orientation polarizability function as described in 
the Lippert-Mataga equation. 
 
To better understand the solvatochromic nature of PHOXI, its spectral shifts were fitted to linear 
functions of a generalized solvent parameter, SP, using empirical solvent parameters described by 
Catalán et al.93, and supplying proportionality constants (See Table 5.2 for a list of solvent parameters 
used in the analysis). Figure 5.12C shows the dependence of PHOXI emission maxima on SP; an 
analogous fit of the emission of Prodan in the same six solvents is included for comparison (constructed 
using previously published Prodan emission data128). For PHOXI, a good linear fit (R2=0.98) was 
achieved when SP = 0.79SPP + 0.12SB + 0.09SA, where SPP is solvent polarity-polarizability, SB is 
solvent basicity, and SA is solvent acidity, while for Prodan the best fit is realized when SP = 0.69SPP + 
0.13SB + 0.18SA. Notably, almost all of the variance in PHOXI spectral shifts is explained by SPP, with 
only minor contributions from acidity and basicity. In fact, a single parameter fit to SPP alone gives 
R2=0.94, suggesting that the dipolar nature of the PHOXI excited state is primarily responsible for the 
observed solvatochromism. In contrast, Prodan fluorescence emission displays roughly twice the 
sensitivity to solvent acidity. For PHOXI, the minor contributions of acidity and basicity are not surprising, 
since it contains both an acidic group (the indolic NH) and a basic group (the oxazole O).  
Variations in PHOXI’s quantum yields, fluorescence lifetimes, and rates of radiative (Γ) and non-
radiative (knr) decay were also analyzed using the Catalán 3P model, and are shown in Figure 5.14. Γ and 
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Both lifetimes and quantum yield increase with solvent polarity, with excellent correlation 
observed for the lifetime fits. The majority of the variation in lifetimes is explained by general solvent 
polarity, but solvent acidity was also found to have a non-negligible contribution. Interestingly, as with 
solvatochromic coumarin probes, PHOXI’s quantum yields increase with solvent polarity, opposing the 
otherwise general trend observed for polarity sensing probes14 (See Figure 4.4, and discussion in section 
4.4.2). This polarity trend is offset by a sizable contribution by solvent acidity, suggesting a possible 
quenching mechanism via accepting an H-bond. The poor correlation for the quantum yield fits is 
explained in part by the uncertainty of the measurements (+/-10%).  Finally both Γ and knr decrease with 
increasing solvent polarity, with minor contributions from SB and SA. Once again the less than perfect fits 
are explained by uncertainties in the quantum yield measurements, which are used to calculate Γ and knr. 
The change between the ground and excited state dipole moments of PHOXI can be ascertained 
from its spectral shifts in solvents of differing polarity by means of the Lippert-Mataga equation10: 
SP = 0.52SPP + 0.04SB - 0.43SA







SP = 0.74SPP - 0.02SB + 0.27SA







































Figure 5.14: Analysis of PHOXI lifetimes, quantum yields, and rates of radiative and non-radia-
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 where γstokes is the Stokes shift expressed as energy, h is Plank’s constant, c is the speed of light, a is the 
Onsanger radius of the solvent cavity occupied by the fluorophore, Δµ is the difference in dipole moments 
between the ground and excited states, and Δf is the orientation polarizability function defined as  
Δf =   
ε− 1
2ε+ 1−   
n! − 1
2n! + 1 
where ε is dielectric constant,  and n is the refractive index of the solvent.  
Because this equation does not take into account the contributions of specific solvent 
interactions, we included the SA term into a multi parameter fit along with Δf, mirroring the analysis of 
PRODAN solvatochromism by Catalán128. Regression analysis of PHOXI Stokes shifts affords: 
γStokes = 15035(0.63Δf + 0.37SA) + 4205 with R2= 0.90 
Accounting for the variance in Stokes shifts caused by SA in the above equation, and substituting into the 
Lippert-Mataga equation gives:  
Δµμ =   
9402  hca!
2  
Assuming an Onsanger cavity radius of 4.94Å, (taken as half of the distance between C4 of the phenyl 
substituent and the indolic N, which are the furthest heavy atoms flanking the PHOXI conjugated system, 
as ascertained from its geometry optimized ground state structure derived by DFT), the transition dipole 
moment of PHOXI is 10.6D, showing evidence of highly-dipolar excited state.  
5.2.4 DFT analysis of PHOXI structure and photophysics 
 Geometry optimization of the ground state structure of PHOXI shows that, unexpectedly, it adopts 
a planar confirmation in all of the solvents studied, with ground state energy decreasing with increasing 
solvent polarity. Time-dependent DFT (TD-DFT) calculations identified the solvent-sensitive, lowest 
energy transition (346.17nm in cyclohexane and 348.31nm in water) as leading to the 1st excited state. In 
both cases, it corresponds to a HOMO to LUMO π-π* transition. 
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5.3 Conclusion and future directions 
In addition to a reliable way for incorporation into specific sites of a biomolecule, this investigation 
of the photophysics of PHOXI revealed that it has many desirable characteristics of a sensitive 
fluorescent reporter tag and reporter of the peptide/protein microenvironment. The fluorescence emission 
spectrum of PHOXI lies in the visible (λEM = 459nm in water), and its high quantum yield (0.54) and 
absorption extinction coefficient contribute to its brightness. Consistent with the above properties, PHOXI 
peptide adducts display visible fluorescence emission and an approximately 5-fold increase in brightness 
relative to unmodified 5HTP peptides. In the context of biological investigations, visible emission enables 
fluorescence microscopy analyses, while high fluorophore brightness allows analyses at lower substrate 
concentrations. 
 PHOXI absorption also shows a significant overlap with the Trp emission envelope, allowing 
PHOXI to act as a FRET acceptor to Trp. The calculated critical Förster distance of 23.5Å for this pair falls 
within the usable range (20-80Å) for distance measurements for biological macromolecules. Since Trp is 
an intrinsic fluorophore, this furthers PHOXI’s utility to provide structural information, and enables it to be 
used in binding assays for Trp containing binding partners. Also of significance here is the fact that 
PHOXI absorption and excitation wavelengths are outside of the Trp absorption envelope, allowing for 
selective excitation of PHOXI in the presence of Trp. As seen in Figure 5.10, when H2N-Trp-PHOXI-OH is 
irradiated with 336nm light, only PHOXI emission is observed, while excitation at 280nm yields both Trp 
emission and PHOXI emission by way of FRET. 
 High sensitivity of PHOXI’s fluorescence emission, lifetimes, and quantum yields to the polarity of 
the surrounding media allows it to be used as a sensitive reporter of the local microenvironment – greatly 
increasing the amount of structural, dynamics, and binding assay data that can be extracted from 
experiments using this probe. It was found that PHOXI’s spectral emission maximum redshifts by 87nm 
when the solvent is changed from the nonpolar cyclohexane to water. Probes exhibiting this degree of 
solvatochromism are highly sought after, and many are rationally designed to impart this property. 
 A comparison of PHOXI’s photophysical properties to other solvatochromic probes with 
absorption below 400nm is shown in Table 5.3. It is important to reiterate that none of these fluorophores 
have the perfect photophysics for any given biological investigation, and none, except for PHOXI, have an 
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intrinsic method of site-specific biosynthetic incorporation. The degree of PHOXI’s solvatochromism is 
comparable to that of Prodan, 6DMN, 4DMP, and Dansyl probes. The extinction coefficient of PHOXI is 
close to the average of the probes listed, and its high quantum yield in polar solvents makes it a great 
alternative to probes such as Fluoroprobe, 6DMN and 4DMP, which exhibit low quantum yields in polar 
solvents. 
Table 5.3: Comparison of PHOXI with solvatochromic probes with absorption <400nm 







λAbs(nm) εmax λFluo QY λFluo QY ΔνFluo Ref. 
(MeOH) (MeOH) (nm) (%) (nm) (%) (cm-1) 
Fluoroprobe 308a 12000 695b <0.1b 476 46 6620 112 
FR0 396 43000 570 19 434 98 5500 96 
Dapoxyl® 
derivatives 373 28000 584 39 457 86 4760 107 
Prodan 361 18400 498 51 417 55 3900 22 
6DMN 382 8000 589 1.2 491 21 3390 98 
4DMP 396 6500 534 12c 457b 62b 3160 97 
Dansyl 
derivatives 335 4600 526 49 471 81 2220 102 
PHOXI 326 15400 437 55 390 69 2760 
 λAbs, absorption maximum; εmax absorption coefficient; λFluo fluorescence emission maximum; QY, quantum 
yield. aData in cyclohexane, bTetrahydrofuran, c1,4-dioxane. 
 
The extinction coefficients, quantum yields, and degree of solvatochromism of PHOXI is 
comparable to that of Prodan, one of the most successful solvatochromic dyes in the realm of biological 
investigations. While PHOXI exhibits moderately lower bathochromic shifts with increasing solvent 
polarity than Prodan, its sensitivity to specific solvent acidity effects is approximately half that of Prodan. 
This more straightforward relationship will help to better ascertain the polarity of protein cavities. Although 
the amino acid analogue of Prodan, Aladan, was recently reported to be an efficient reporter of protein 
electrostatics in Shaker potassium channel and Kir2.1 proteins113a, its sensitivity to H-bond donors 
complicates the attribution of such data to polarity of protein cavities.  In fact, Catalán has cautioned of 
attributing such spectral data to general polarity effects128, theorizing that the high polarity of the heme 
binding pocket in apomyoglobin as ascertained from Prodan fluorescence129 can also be attributable to 
specific interactions with nearby NH sites.  
Furthermore, the molecular structure of PHOXI does not resemble the traditional scaffold of 
electron donor/acceptor moieties flanking an aromatic system that is the hallmark of other solvatochromic 
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dyes. This elucidates an alternative approach in rational design of such probes. Earlier studies show that 
oxidation of 5HI in the presence of a series of primary amines, produces a number of structural analogues 
of PHOXI, which bear other alkyl and aryl groups in place of its phenyl substituent18a, 19, 117. Furthermore, 
the closely related 6-hydroxyindole displays the same pattern of reactivity as 5HI, except that amines add 
to the 7 indolic position, resulting in a series of 8H-oxazolo[5,4-g]indoles117.  This opens up a possibility of 
investigating a whole library of PHOXI-like compounds as potential fluorophores, and further honing their 
photophysical properties. 
In conclusion, this work represents a valuable addition to the field of peptide and protein 
solvatochromic fluorophore development. Not only does PHOXI itself make a valuable addition to the 
arsenal of polarity sensing probes because of its photophysics and built-in incorporation ability, but its 
unique structure suggest alternative routes for the design of such molecules. Finally, although the 
chemistry of 5HI oxidation in the presence of amines has long been known, this project describes its 
application to fluorophore development for the first time. Thus, this body of knowledge of the reactivity of 
5HI and related systems can now be tapped to develop a collection of PHOXI analogues that can 
combine fluorescence with affinity purification tags, or have even more desirable spectral properties.  
5.4 Materials and Methods 
Materials.  
 NH2-Trp-5HTP-OH  (98.3% purity) and human Aβ-40 peptide (purity 98%) were purchased from 
Lifetein (Hillsborough, NJ); 5HTP-TrpZip2 (SWT-5HTP-ENGKWTWK) (99% purity) was custom 
synthesized by Peptide 2.0 (Chantily, VA). The purity of all peptides was confirmed by HPLC prior to use. 
Benzylamine (99%) was purchased from Acros Organics (Geel, Belgium), and distilled before use. 5-
hydroxyindole (97%) was purchased from Aldrich (St. Louis, MO) and purified by sublimation prior to use.  
Preparation of 2-phenyl-6H-oxazolo[4,5-e]indole (PHOXI). 2-phenyl-6H-oxazolo[4,5-e]indole was 
prepared from 5-hydroxyindole and benzylamine by adapting a procedure described by Boger et al117. 
Briefly, 0.375mmol 5HI and 0.45mmol benzylamine were dissolved in 40mL of dry dichloromethane and 
cooled to 0°C under N2. 1.75g of activated MnO2 was then added and the reaction was allowed to warm 
to room temperature. After 4 hours, the reaction mixture was filtered through celite, and solvent was 
evaporated under reduced pressure. The residue containing the fluorescent product (Rf = 0.41 (DCM)) 
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was purified by silica gel flash column chromatography eluted with 10% ethyl acetate in petroleum ether. 
PHOXI 1H-NMR (CDCl3, 400MHz): δ 8.51 (br, 1H), δ 8.31-8.32 (m, 2H), δ7.52-7.53 (m, 3H), δ7.38-7.43 
(dd, 2H), δ7.36(br,1H), δ7.04 (br, 1H). The 1H-NMR data are consistent with previously published reports 
for 2-phenyl-6H-oxazolo[4,5-e]indole 
5.4.1 Recombinant Expression and selective pressure incorporation of 5HTP into proteins 
GST 
The plasmid vector pET41b+ coding for GST was transformed into E. Coli BL-21(DE3) 
expression hosts by heat shock, and positive transformants were selected by plating on LB plates 
containing 30mg/L Kanamycin. For analogue incorporation, cells were initially grown in “rich media” 
(10g/L N-Z Amine, 5g/L NaCl, 10g/L Tryptone, 4g/L Glucose, 30mg/L Kanamycin) at 37°C and 250rpm 
until an OD600 ~0.7 was reached. The cells were then harvested from culture by gentle centrifugation 
(5min, 4000 x g, 37°C) and resuspended in prewarmed “minimal media” (50 mM Na2HPO4, 50 mM 
KH2PO4, 2 g/L D-glucose, 2 g/L NH4Cl, 20 mM Sodium Citrate, 1 x 5052130, 1g/L glyphosate, 60mg/L 
5HTP, 60mg/mL Phe, 60mg/mL Tyr, 30mg/L Kanamycin). After a 30 min incubation at 37°C and 250rpm 
to exhaust remaining tryptophan stores, expression was induced by addition of 1mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). Total cell protein extracts were prepared at 1, 2, 3, 4, and 12hours after 
induction and analyzed by SDS-PAGE. Maximum production of GST was at 3 hours post induction (~10% 
of total cell protein). The cells were harvested by centrifugation (10min, 10000 x g, 4°C), and the pellets 
immediately stored at -80°C for subsequent purification. 6 x His Tag purification was conducted under 
native conditions using Qiagen Ni-NTA agarose following the manufacturer’s batch purification protocol, 
and followed by SDS-PAGE.  
Horse Skeletal Muscle Myoglobin 
The amino acid sequence for this HMb, (Uniport ID: P68082), was back-translated using codons 
otpitimized for E. coli expression, and appended with nucleotide sequences introducing an N-terminal 
NdeI site, and a C-terminal 6 x His sequence and XhoI site. This construct was synthesized by IDT DNA 
and delivered in the pIDTBlue cloning vecor. pIDTBlue(HMb) was then used to transform BL21 competent 
cells by heat shock, and positive transformants were selected by plating on LB-kanamycin plates.  
Plasmid DNA was extracted from overnight LB cultures using QiagenMiniprep kit, according to the 
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manufacturer’s protocol. Both pIDTBlue(HMb) and pET41b+ were subjected to double restriction 
endonuclease digestion with NdeI and XhoI according to the manufacter’s protocol (New England 
Biolabs(NEB)). Digested DNA was separated on a 1% agarose gel, and the bands corresponding to HMb 
and linearized pET41b+ were excised. DNA was extracted from the gel using the Agilent Strataprep kit 
according to the manufacturer’s protocol. The vector backbone was dephosphorylated with arctic alkaline 
phosphatase (NEB) prior to overnight ligation with HMb insert with T4 DNA ligase(NEB) according to the 
manufacturer’s protocol. Aliquots of the ligation reaction were used to transform BL-21(DE3) host cells, 
and positive clones were selected by plating on LB-kanamycin plates, and sent for sequencing to confirm 
correct orientation and reading frame of the plasmid construct (pET41b+HMb). 
Expression was performed as described for GST. For expression using the pQE system, the coding 
sequence was now appended with NcoI and BglII sites, and supplied as a double stranded gBlock from 
IDT DNA. The insert and the vector pQE60 were subjected to double digestion by NcoI and BglII (NEB), 
and subjected to the same purification, dephosphorylation, and ligation procedure as described for 
pET41b+HMb assembly. Heat shock competent cells were prepared from E. coli strains M15 and 
SG13009 (Qiagen) according to the manufacturer’s protocol and were transformed with ligation mixtures. 
Selection of positive clones was done by plating on LB-ampicillin plates. Positive clones from both M15 
and SG13009 strains were confirmed by sequencing. 
5.4.2 PHOXI derivatization of peptides 
 For optimization of derivatization conditions, 10-100µM of 5HTP-containing or control peptide was 
dissolved in 0.5M borate buffer, pH 8.0 in the presence or absence of 0.5M benzylamine in an HPLC 
microvial. The reactions were initiated by addition of K3[Fe(CN)6] to a final concentration of 2mM. After 10 
minutes, the reactions were stopped and the products analyzed by direct injection onto a Series 200 
HPLC system (Perkin Elmer, Waltham, MA) equipped with an XBridge C18 4.5 X 150mm column (Waters 
Corporation, Milford, MA). The products were separated by eluting with a linear gradient of Buffer A (0.1% 
TFA in water) and buffer B (0.1% TFA in Acetonitrile) at a flow rate of 1mL/min as follows: 5 min 100% 
Buffer A, 2 minutes increasing to 20% Buffer B, 20 min increasing to 40% buffer B. The products and 
unreacted starting materials were visualized by a UV-Vis flow-cell detector at 220nm (peptide amide 
bonds), 280nm (Tryptophan and/or 5HTP) and 326nm (PHOXI).  Product peaks with appreciable 
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absorption at 326nm were manually collected, lyophilized and subjected to mass spectrometry to confirm 
identity of PHOXI derivatized products. Lyophilized NH2-TRP-5HTP-OH derivatization products were 
dissolved in 50% Acetonitrile containing 0.1% formic acid and analyzed by direct infusion onto an Agilent 
6220 ESI-TOF mass spectrometer. TrpZip2 derivatization products were analyzed using a MALDI-LTQ 
XL orbitrap mass spectrometer (ThermoFisher Scientific, Waltham, MA) using α-Cyano-4-
hydroxycinnamic acid as matrix. 
5.4.3 Spectroscopic Measurements 
Absorbance measurements.  
Background corrected absorption spectra were recorded on a Lambda 650 UV−vis 
spectrophotometer (Perkin Elmer, Walnut Creek, CA) with a 2 nm slit width, 1 cm path length, and 1 nm 
interval. Extinction coefficients of Trp (5.69 × 103 M-1cm-1) 5HTP (4.5 × 103 M-1cm-1) and PHOXI (1.54 × 
104 M-1cm-1) were used to determine concentrations.   
Steady-State Fluorescence Emission Measurements  
Fluorescence emission spectra of PHOXI derivatized peptides in water, and of PHOXI in neat 
solvents were recorded on a Fluorolog 3 model FL-1000 (Horiba Jobin Yvon, Edison, NJ) fluorometer. For 
PHOXI derivatized peptides, emission spectra were recorded with an excitation wavelength of 280 nm 
(Trp) and 336nm (PHOXI). For quantum yield measurements of PHOXI in neat solvents, the excitation 
wavelength used corresponded to maximum excitation of PHOXI in each solvent (332nm for acetonitrile; 
336nm for 1,4-dioxane, methanol, toluene and water), except for cyclohexane, where 322nm had to be 
used to obtain a complete emission profile. For all fluorescence measurements, the step size was 1nm, 
the integration time was set to 0.1 s. The slit width was 2nm and matched that of absorption 
spectrophotometer. All concentrations were < 0.01 mM to avoid inner filter effects.  
Quantum Yield Determination.  
Aqueous quinine sulfate (QY = 0.54)131 and harmane (QY = 0.83)132 in 0.1 M sulfuric acid were used as 
quantum yield standards. PHOXI quantum yields in six neat solvents were determined by the method 
described by Williams et al.133 Briefly, the quantum yield of the two quantum yield standards are first 
determined via reference against each other to ensure confidence in quantum yields measured for the 
unknown. The integrated fluorescence intensity of each fluorophore is determined from emission spectra 
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at several fluorophore concentrations, all less than 0.01 mM, to avoid the inner filter effect. The integrated 
intensity is plotted as a function of the measured absorbance at each concentration. A linear fit is 
calculated, ensuring that the fit line runs through the origin. Obviously, the goodness-of-fit should be close 
to unity. The slope of the fit is the gradient, G, used in calculation of the quantum yield, QY: 





where the subscript, st, signifies the quantities for the quantum yield standard, and x are the quantities for 
the fluorophore of unknown quantum yield. n is the refractive index for each solution: n = 1.333 for water, 
n = 1.334 for 0.1 M sulfuric acid, n = 1.497 for toluene, n = 1.427 for cyclohexane, n = 1.331 for methanol, 
n = 1.344 for acetonitrile, n = 1.422 for 1,4-dioxane.134 
Trp-PHOXI Förster Distance Calculation. 
The Förster distance was calculated using the equation10: 
𝑅! = 0.2108 𝑘!𝛷!"#𝑛!!𝐽
!
!
Where R0 is the critical Förster distance in angstroms, k is the dipole orientation factor and was set to 2/3 
(assuming rotation of molecular dipoles is much faster than FRET rate), ΦTrp is the quantum yield of Trp in 
water (0.14), n is the refractive index of the medium taken as 1.4 for biological macromolecules, and J is 





Where FTrp(λ) is the fluorescence emission of Trp normalized to unity, and εPHOXI(λ) is the normalized 
absorption spectrum of PHOXI scaled to its extinction coefficient ε326nm = 15400 cm-1M-1. 
Time-Resolved Fluorescence Lifetime Decay Measurements.  
Fluorescence lifetime measurements of PHOXI in six neat solvents were carried out on a 
commercial instrument that employs a laser diode excitation source with a broad (1.47 ns) instrument 
response function (Horiba Jobin Yvon, Edison, NJ). Excitation at 340nm was achieved with a NanoLED 
source (<1ns pulse). An experimental instrument response function, necessary for proper deconvolution, 
was collected from scattered light from an aqueous casein solution at 340nm.  
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PHOXI Photodegradation Assays: 
A 0.33µM solution of PHOXI in either toluene or water in a 50µL quartz microcuvette was 
illuminated by a Xenon lamp of a Fluorolog spectrofluorimeter at 336nm for 5000s. The lamp power at the 
cuvette was 8.5mW and the illumination area was 3mm H x 2mmW.  Emission and excitation 
monochromator slits were set to 8nm. During illumination the fluorescence at the maximum (459nm for 
Water, 390nm for Toluene) was recorded at 1s intervals. The percentile fraction of residual fluorescence 
signal after an hour of illumination was recorded. 
Fluorescence Lifetime Decay Analysis:  
The lifetimes for decays collected on the diode instrument were determined by iterative 
convolution using the vendor-provided decay analysis software, DAS6. Details of this method are 
described by Eisenberg and Juszczak.135 
Circular Dichroism of PHOXI and 5HTP containing TrpZip2 peptide.  
A Chirascan CD spectrophotometer (Applied Photophysics,) equipped with a sample temperature 
controller unit was used to obtain CD spectra of 25µM aqueous solutions of TrpZip2 peptides bearing 
either 5HTP or PHOXI in place of Trp 4. For each peptide, spectra were recorded at 25°C, 65°C and 
80°C. 
5.4.4 DFT calculations 
Calculations were submitted with the help of Dr. Azaria Eisenberg. Gaussian 09 software was 
used for ab initio quantum mechanical calculations. The ground-state structure was optimized using the 
B3LYP density functional theory method and 6-311G* basis set, with an ultrafine grid. The polarizable 
continuum method with implicit solvents were used to allow for the solvent effects, and the structure was 
checked for imaginary frequencies to insure that it was not in a transition state. Excited state calculations 
were done with the same B3LYP method and basis set. Calculations were done on the BOB system at 
the CUNY High Performance Computing Center. 
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